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CHAPTER 1. GENERAL INTRODUCTION 
Research Problem: Chronic intestinal inflammation, as seen with inflammatory bowel 
disease in humans, results from aberrant and poorly understood mucosal immune responses 
to intraluminal bacteria of the gastrointestinal tract in genetically susceptible individuals. 
Although considerable research evidence indicates that luminal bacteria provide the antigenic 
stimulation for intestinal inflammation, the evaluation of bacterial-specific host responses 
mediating intestinal injury (as a consequence of changes in the composition of the resident 
enteric flora) have not been performed. 
Overview of Inflammatory Bowel Disease in Humans: 
Introduction 
The chronic idiopathic inflammatory bowel diseases (DBD), which include Crohn's 
disease (CD), and ulcerative colitis (UC), are recognized as important causes of 
gastrointestinal disease in adults and children. Inflammatory bowel disease occurs 
worldwide, although it is more common in some regions (e.g., United States, United 
Kingdom, and Scandinavia) than in others with incidence rates of4-10/100,000 persons per 
year and prevalence rates between 40-100/100,000 persons.(l) These disorders are most 
commonly diagnosed between the third and fourth decades of life, with no difference noted 
between males and females. Approximately 20% of all patients with DBD develop symptoms 
during childhood, with about 5% being diagnosed before 10 years of age. The ratio of UC to 
CD varies widely according to the country of origin of the survey but in most countries UC is 
found with greater frequency than CD.(2) 
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Defining Ulcerative Colitis and Crohn's Disease 
Ulcerative Colitis 
Ulcerative colitis is a disease in which the inflammatory response and histological 
changes are localized to the colon. The rectum is affected in 95% of patients with variable 
degrees of proximal extension. Inflammation is limited primarily to the mucosa and consists 
of diffuse involvement of variable severity with ulceration, edema, and hemorrhage 
predominating along the length of the colon. The characteristic histologic findings are 
lamina propria infiltration with mononuclear cells and neutrophils, crypt abcessation, 
distortion of the mucosal glands, and goblet cell depletion. 
Crohn's Disease 
In contrast to UC, CD can involve any part of the gastrointestinal tract but also 
primarily involves the colon. Diseased segments frequently are separated by intervening 
normal bowel (e.g., patchy lesion distribution) with severe inflammation typically occurring 
as a transmural lesion. Histologic findings include small ulcerations, focal chronic 
inflammation extending down to the submucosa, and sometimes granuloma formation. The 
most common location for lesions is the ileocecal region, followed by the terminal ileum 
alone, diffuse small bowel involvement or focal colonic disease in decreasing order of 
frequency (e.g., ileocecal region>terminal ileum>small intestine.colon). 
Intestinal Manifestations of Disease 
Ulcerative Colitis 
The most consistent feature of UC is the presence of blood and mucus in the stool, 
accompanied by lower abdominal cramping. The presence of diarrhea with blood and 
mucous as opposed to the absence to blood is used clinically to differentiate UC from 
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irritable bowel syndrome, an important and clinically-relevant IBD mimic. Ulcerative colitis 
is usually diagnosed earlier after the onset of symptoms than is CD because of the presence 
of blood in the stool, which generally alerts the person to the presence of a primary 
gastrointestinal disorder. Abdominal pain (cramping) is often present in the left lower 
quadrant with distal disease, and this discomfort may extend to involve the entire abdomen 
with pancolitis. Pediatric patients tend to have a higher frequency of pancolitis, a higher 
likelihood of proximal extension of the disease over time, and a higher risk of surgical 
intervention (e.g., colectomy) compared to adult-onset patients.(3) 
Crohn's Disease 
In contrast to UC, the presentation of CD is often subtle leading to a delay in 
definitive diagnosis. Gastrointestinal symptoms depend upon the location, extent, and 
severity of inflammation. Gastroduodenal CD presents with early nausea, vomiting, 
epigastric pain, and/or dysphagia. Due to post-prandial pain and a delay in gastric emptying, 
patients with gastroduodenal CD often limit their caloric intake to diminish their discomfort. 
Colonic CD may mimic UC in that patients may present with diarrhea containing blood and 
mucous, lower abdominal cramping, and pain on defecation. Perianal disease is common, as 
are anal fissures and fistulae. Increasing abdominal cramping, distension, and emesis 
accompanied by borborygmi (e.g., intestinal "gurgling" are signs of progression of the 
inflammatory process to focal luminal stenosis causing partial/complete obstruction. 
The course of IBD may be complicated by one or more extraintestinal manifestations 
including fever, weight loss, delayed growth and sexual maturation in children, 
arthralgia/arthritis, mucocutaneous lesions, ophthalmologic complications, hepatobiliary 
disease, and/or renal disease.(4) These extraintestinal lesions may be diagnosed concurrently 
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with active bowel disease, following a flare of IBD, or occasionally, may be the initial 
presentation of IBD preceding intestinal symptomatology. 
Diagnosis of IBD 
The importance of excluding enteric pathogens before confirming a diagnosis of IBD, 
or during IBD exacerbations, cannot be overemphasized. There are a diverse number of 
bacterial pathogens that may mimic IBD and are discussed in a separate section of this 
dissertation. Once enteric infections are excluded, further diagnostic evaluation, including 
endoscopic mucosal biopsy which is required for definitive diagnosis, is performed (Table 1). 
Test Finding 
Complete blood counts 
Acute-phase reactants 
Chemistries 
Microcytic anemia, leukocytosis with band forms, thrombocytosis 
Elevated sedimentation rate and serum orosomucoid, and C-reactive 
protein levels 
Low serum iron level, hypoalbuminemia. elevated liver enzyme levels 
Special serologic tests 
Stool examinations.* 
Endoscopic evaluation 
Radiologic evaluation 
pANCA, ASCA 
Exclude bacterial pathogens, ova and parasites, occult blood, and 
' fecal leukocytes 
..... Esophagogastroduodenoscopy with biopsy, colonoscopy with biopsy 
Upper gastrointestinal tract with small bowel follow-through, 
enteroclysis (as indicated), barium enema 
Table 1. Diagnostic tests for IBD. These tests are generally performed in a step-wise 
manner but always require histopathologic evaluation of intestinal biopsy specimens for 
diagnosis. pANCA= perinuclear anti-neutrophil cytoplasmic antibody; ASCA= anti-
Saccharomyces cerevisiae antibodies. Modified from Hendrickson BA, Gokhale R, Cho J. 
Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Micro Rev 2002; 
15:79-94. 
Treatment of IBD 
The management of IBD involves several strategies including: (1) control of acute 
symptoms (e.g., diarrhea, obstruction, megacolon), (2) induction and maintenance of 
remission (generally with corticosteroids, 5-ASA derivatives [sulfaslazine], antibiotics 
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[metronidazole, ciprofloxacin], immunosuppressive drugs [azathioprine, cyclosporine], and 
biologic therapies [infliximab -> a novel TNF-a monoclonal antibody], (3) surgical 
intervention for masses and stenoses, (4) nutritional support [dietary modification, use of 
pre/probiotics] and (5) cancer surveillance. 
Prognosis of UC and CD 
The long-term prognosis for patients with IBD is extremely variable and is a 
consequence of differences in disease extent, frequency, and severity of disease. For UC, the 
relapse rate is approximately 40% during the first year following intensive medical therapy 
with an additional 13% and 16% during the second and third years, respectively.(5) Most of 
these relapses may be controlled with medical therapy, but surgery will be required in 
approximately 1/3 of patients necessitating intensive treatment for complications (e.g., toxic 
dilatation of the colon).(6,7) For CD, the need for surgery occurs in greater than 50% of 
patients and a majority of patients will experience recurrent disease with the need for 
subsequent operative intervention. (8) The prognosis of IBD must also take into account the 
increased risk of colon carcinoma that is present in patients who have pan-UC for more than 
8 years (9), but which may also occur in patients who have CD for more than 15 years.(lO) 
As a result, it is recommended that high risk patients who have IBD undergo endoscopic 
surveillance with multiple colonic biopsies as part of the long-term management of their 
disease. 
In summary, idiopathic IBD represents two distinct entities that share a number of 
clinical similarities and disease manifestations. Although the exact cause for UC and CD 
remains unknown, it is reasonable to expect that the further development and use of animal 
models to explore mechanisms of gastrointestinal inflammation will be important. 
6 
Additionally, animal models will continue to provide important insights into the cause for 
IBD in humans, as well as aid in the design of more effective treatment modalities. 
ETIOPATHOGENESIS OF INFLAMMATORY BOWEL DISEASE: MICROBIAL 
INFLUENCES IN ANIMAL MODELS OF DISEASE 
Hypotheses Regarding Etiopathogenesis 
Human inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative 
colitis, are poorly understood chronic immunologically-mediated diseases of unknown 
etiology.(ll) Although numerous questions regarding the cause for IBD remain, familial and 
epidemiologic data indicate that these debilitating intestinal inflammatory disorders result 
from complex interactions between a genetically susceptible host, the mucosal immune 
system, and environmental factors.(12) (Figure 1) 
Figure 1. Host-microbial-environmental interactions which contribute to the development of 
IBD. Note that microbial factors consist of adjuvants and antigens derived from commensal 
enteric bacteria. With a loss of tolerance, the scale is tipped toward mucosal inflammation 
which may culminate in IBD. 
Environmental 
triggers 
Luminal antigens 
and adjuvants 
Host genetic 
susceptibility 
Normal 
Tolerance Loss of 
Tolerance 
(Microflora?) 
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However, neither the specific genes or environmental triggers have been conclusively 
identified. Although the preponderance of data indicates that commensal luminal bacterial 
constituents provide the constant antigenic drive for chronic intestinal inflammation, other 
possibilities include dietary contributions, persistent pathogens, and alterations of the 
virulence factors of commensal bacteria.(13) This section will briefly discuss the most 
widely accepted etiologic hypotheses for IBD (Table 2). 
Table 2. Etiologic theories for IBD 
Persistent pathogen: Mycobacterium paratuberculosis, virulent E. coli 
Pseudomonas species, Listeria monocytogenes, Helicobacter 
species, measles 
Defective clearance of pathogenic and commensal bacteria 
Defective mucosal barrier: enhanced permeability, ineffective healing 
Dysbiosis: altered balance of protective/detrimental commensals 
Dysregulated immune response: overly aggressive effectors, loss of tolerance 
Table 2. Etiologic theories for IBD. Modified from Sartor RB. Microbial influences in 
inflammatory bowel diseases: role in pathogenesis and clinical implications. In: Sartor RB, 
Sandbom WJ, eds. Kirsner's Inflammatory Bowel Diseases, 6th edn. London: Elsevier 2004, 
page 148. 
Persistent Pathogenic Infection 
A number of microbial pathogens have been proposed as causes of UC or CD, 
including Mycobacterium paratuberculosis, adherent/invasive E.coli, Pseudomonas spp., 
Listeria monocytogenes, or Helicobacter species. To date, the vast majority of these 
organisms have not been confirmed by blinded, controlled investigations. Adherent/invasive 
E.coli may contribute to post-operative recurrence of Crohn's disease and the role of 
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Helicobacter species has yet to be fully explored. The availability of sensitive molecular 
techniques to detect microbial agents may yet allow identification of a specific bacterial 
pathogen. 
Impaired Clearance of Pathogenic and Commensal Organisms 
Defective killing of invading commensal bacteria, opportunistic bacteria, or 
traditional enteric pathogens may cause tissue inflammation and the induction of pathogenic 
immune responses. Some humans with CD have defective neutrophil function.(14) It has 
been shown that some Bacteroides species impair neutrophil phagocytosis and microbicidal 
activity, suggesting that enteric bacteria mediate these defects. It is noteworthy that 
microbial products can also inhibit host defenses. Bacteroides species may decrease 
neutrophil phagocytosis and bacterial killing (15) and defective T-cell function may foster 
the growth of opportunistic pathogens, such as intestinal Helicobacters which cause typhlitis 
and hepatobiliary disease in T-cell deficient mice.(16) Lastly, suppression of neutrophil 
function by nicotine and the administration of non-steroidal anti-inflammatory drugs 
(NSAIDs) could explain several other environmental risk factors for CD. 
Defective Mucosal Barrier Function 
Intrinsic (genetically determined) or acquired (environmental agent) defects in 
mucosal barrier function or healing can lead to continuous uptake of luminal antigens that 
overwhelm host protective mechanisms. Endogenous luminal bacteria and their phlogistic 
products traverse the inflamed mucosa in IBD, especially in CD and experimental 
enterocolitis.(17) A correlation between disease activity and altered mucosal permeability in 
both CD and UC, and enhanced permeability predicting flares of CD, has been previously 
reported. ( 18-20) Additionally, increased uptake of bacterial products derived from 
9 
translocating bacteria suggests an intrinsic defect in mucosal barrier function which may 
precipitate intestinal inflammation. Previous studies have shown that mucosally-associated 
bacterial concentrations are dramatically increased in IBD patients.(21) 
Altered Balance of Protective/Detrimental Commensal Bacteria 
Normal (otherwise healthy) hosts may develop chronic intestinal inflammation as a 
consequence of altered composition of commensal enteric bacteria. The balance between 
beneficial and detrimental enteric bacteria appears to be disturbed in patients with IBD, 
especially in the western, industrialized populations where IBD is most prevalent. In brief, 
increased fecal concentrations of intestinal bacteria (predominantly anaerobes) are present in 
CD patients and their asymptomatic relatives.(22) Similar observations in experimental 
models have demonstrated the inflammatory potential of bacterial species, providing 
additional support for the concept that composition of the resident microflora modulates 
disease severity. Similar to human IBD, streptococci, clostridial species, and Bacteroides 
(particularly B. vulgatus) may cause colitis in specific animal models. In contrast, 
lactobacilli and bifidobacteria have protective roles in pro-biotic and pre-biotic studies. 
Disregulated Immune Responses to Commensal Bacteria (Loss of Tolerance) 
Human DBD patients and rodents with chronic intestinal inflammation have 
exaggerated humoral and cellular immune responses to commensal bacteria and/or microbial 
pathogens. A Thl cytokine profile is found in CD patients (23) and most animal models. 
(24) On the other hand, UC evokes a mixed Thl :Th2 profile (25) and several rodent models, 
such as the TCRav" mice, have a Th2 dominant response (26). Mechanisms of immune cell 
regulation largely depend on the interplay between antigen presenting cells (APC) and T 
lymphocytes. In normal hosts, regulatory T cells and APC inhibit pathogenic immune 
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responses to commensal bacteria (e.g., the phenomenon of immune tolerance) by several 
pathways including IL-10 and TGF-(3 secretion. Taken together, the observations 
predominantly made in animal models (see below) demonstrate (1) the importance of 
interacting innate and acquired immune responses, (2) the complex regulation of tolerance to 
luminal bacteria, and (3) the many potential mechanisms by which genetically-determined 
defects in immunoregulation can lead to chronic, immune-mediated intestinal inflammation. 
Animal Models of Intestinal Inflammation 
Recent advances in experimental animal models have enhanced our understanding of 
the contributions of mucosal immunity in IBD. The advantages of such models include the 
use of inbred strains of mice, as well as standardized housing conditions and diet that 
minimize inter-subject variation during initial onset and development of disease. The main 
limitation is that none of the current animal models reproduce human IBD completely. A 
large number of animal models exist, and they may be categorized into (a) those in which 
disease spontaneously arises, (b) those in which disease is induced with exogenous reagents, 
(c) those where disease occurs secondary to genetic manipulation, and (d) those involving 
transfer of immune cells to immunodeficient animals which subsequently develop 
disease.(27,28) (Table 3) 
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Table 3. Categories of animal models of intestinal inflammation 
based on method of induction 
Induced Spontaneous Genetic T-cell transfer 
Acetic acid Cotton-top HLA-B27p2g TG rat CD45RBl"-»-SCID 
Immune complex/formalin tamarin IL-2" " BM-*-CD3eTG 
Carageenan C3H/Hej Bir IL-7™ TG 
DSS Samp-1 /Yit IL-10-/~, IL-1 OR 
Indomethacin TCRor'-
TNBS/alcohol Gir/.2~'~ 
PG-PS Mdr la"'" 
Oxazalone N-cadherin DN 
Methotrexate A20 ' 
TNF^ 
STAT-3 ' 
STAT-4 
T-betTG 
WASP 
-/-, deficient, knockout; DN, dominate negative; TO, transgenic; BM, bone marrow. 
Table 3. Categories of animal models of intestinal inflammation based on the method of 
injury induction. DSS = dextran sodium sulfate; TNBS= trinitrobenezene sulfonic acid; PG-
PS=peptidoglycan-polysaccharide; WASP= Wiskott-Aldrich syndrome protein; 
SCID=severe combined immunodeficiency; mdr=multidrug resistance. Modified from 
Sartor RB. Animal models of intestinal inflammation. In: Sartor RB, Sandbom WJ, eds. 
Kirsner's Inflammatory Bowel Diseases, 6th edn. London: Elsevier 2004, page 121. 
Spontaneous colitis that develops in cotton top tamarins resembles IBD.(29) 
Additionally, C3H/HeJBir mice develop predominantly right-sided colitis early in life that 
largely resolves by 3 months of age.(30) Experimental colitis may be induced by a variety of 
chemical or natural substances that damage the intestinal mucosa and produce inflammation, 
such as acetic acid, dextran sodium sulfate (DSS), trinitrobenzenesulfonic acid (TNBS) or 
oxazolone together with ethanol, peptidoglycan polysaccharide, indomethacin, or 
carrageenan. (31 -34) Other models have been generated by gene-targeting methods to 
produce intestinal inflammation when rodents are housed under conventional conditions. 
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Several of these models utilize mice with specific mutations that affect cytokine secretion or 
CD4+ T cell populations. In IL-2 deficient (IL-2"/") mice, an IL-12-driven Thl response, 
characterized by high IFN-y, results in the development of colonic inflammation with crypt 
hyperplasia, focal ulceration, and infiltration of the lamina propria with mononuclear 
cells.(35,36) Subsequent studies have suggested that CD4+ T cells, but not B cells, are 
critical to the pathogenesis of mucosal injury in IL-2"7" mice.(37) Similarly, IL-10 deficient 
(IL-10" ") mice develop a chronic enterocolitis mediated by Thl lymphocytes which 
synthesize IL-12 and pro-inflammatory cytokines such as IFN-y and TNF.(38,39) 
Colitis with crypt distortion and lamina proprial cellular infiltrate has also been 
observed in mice with targeted mutations of either T-cell receptor a or T-cell receptor J3 
genes.(40) Furthermore, rats transgenic for HLA-B27 spontaneously develop a predominant 
CD4+ T cell-mediated colitis and gastritis when raised in conventional or SPF 
environments .(41) Other investigations have shown that defects in macrophage function may 
contribute to intestinal inflammation. In this regard, mice lacking transcription factor STAT-
3 have macrophages that fail to be inhibited by IL-10, a key anti-inflammatory cytokine.(42) 
The requirement for a protective epithelial barrier to luminal antigens or bacteria has been 
demonstrated by several novel models. Mice with altered N-cadherin expression in the 
intestine develop patchy IBD resembling CD.(43) Other mice, having a defect in the multi­
drug resistance gene (mdr-1), show intestinal inflammation similar to UC.(44) Another 
example includes mice lacking intestinal trefoil factor which die of extensive colitis after 
administration of dextran sulfate sodium. (45) 
Lastly, the adoptive transfer of CD4+ T cells expressing CD45RBhlghinto an 
immunodeficient animal (i.e., SCID mouse) causes systemic wasting and a Thl-mediated 
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colitis. (46) In addition, transfer of the reciprocal population, CD45RBlow, with the 
pathogenic CD45RBhlgh subset prevents colitis. Protection of colitis in this model by this 
CD45RBlow subset of CD4+ T cells is due to their ability to downregulate immune responses; 
and thus, they are referred to as regulatory T cells. Further work has shown that these 
regulatory cells express CD25, and exert their effects through the production of cytokines 
TGF-P and IL-10.(47-49) These studies indicate that the balance between mucosal 
inflammation and oral tolerance depends upon the presence of different CD4+ T cell subsets, 
and that the protective effects are mediated by the synthesis and release of regulatory 
cytokines. The importance of regulatory cytokines has been further demonstrated recently; 
whereas, the severity of murine colitis can be reduced when mice are given Lactococcus 
lactis genetically engineered to secrete IL-10.(50) 
Role of the microflora in IBD 
Both clinical observations and animal models support the hypothesis that aberrant 
immune responses to resident (commensal) luminal bacteria drive chronic inflammation in 
genetically susceptible hosts (Table 4). Clinical improvement and decreased intestinal 
inflammation is observed in humans with IBD when intestinal bacteria are decreased by 
antibiotic administration.(51,52) Rodent models of IBD demonstrate marked reductions in 
clinical and histologic signs of intestinal inflammation when the animals are housed in a 
germ-free environment.(27,53-55) Collectively, these data indicate that inappropriate 
responses triggered by bacterial antigens may dictate the onset and/or maintenance of colitis 
as much as, or even more than, predisposing genetic factors. 
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Table 4. The influence of the resident bacterial environment 
on inflammation in animal models 
Model Species SPF Germ-Free Antibiotics 
A. Induced disease 
Indomethacin Rat 
C'irraqeenan Guinea pig 
DSS 
TNBS 
Mouse 
Rat 
Acute SB, colonic 
and gastric iilccrs. 
chronic SB ulcers 
Cecal 
infiam nation 
Colitis 
Colitis 
Attenuated acute, 
Usent chronic 
No colitis 
t or I colitis 
ND 
4 by metronidazole, 
tetracycline 
4 by metronidazole, 
clindamycin 
4 by Cipro, 
imipenum/ 
vancomycin 
(acute phase) 
f by amoxicillin, 
davulanic acid 
B. Genetically engineered 
HLA-B27 Rat 
transgenic 
CD45 RB 
-» SCID 
IL-2 ' 
IL-10" 
TCRa-'-
mdr lu" 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Gastritis, colitis, 
arthritis 
Colitis 
Colitis, gastritis, 
hepatitis 
Colitis 
Culitis 
Colitis 
No Gl or joint 4 by metronidazole 
inflammation vancomycin/ 
imipenum 
No colitis 4 by streptomycin 
and b.uitMcin 
Absent-attenuated ND 
inflammation 
No colitis 4 by metronidazole, 
Cipro, vancomycin, 
imipenum 
No inflammation ND 
ND 4 by streptomycin, 
neomycin, bacitracin, 
amphoteracin' 
C. Spontaneous mutations 
Samp l/Yit Mouse 4 metronidazole/ No ileitis 
Co t s Cotton-top Marmoset 
tamarin 
SB, small bowel; Gl, gastrointestinal; ND, not done; 4, attenuation of disease; f, potentiation of disease. 
Table 4. The influence of the resident bacterial flora on inflammation in animal models. 
Note that select models are included and that this list is not exhaustive. DSS = dextran 
sodium sulfate; TNBS= trinitrobenezene sulfonic acid; PG-PS=peptidoglycan-
polysaccharide; WASP= Wiskott-Aldrich syndrome protein; SCID=severe combined 
immunodeficiency; mdr=multidrug resistance. Modified from Sartor RB. Microbial 
influences in inflammatory bowel diseases: role in pathogenesis and clinical implications. In: 
Sartor RB, Sandbom WJ, eds. Kirsner's Inflammatory Bowel Diseases, 6th edn. London: 
Elsevier 2004, page 145. 
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The lumen of the distal ileum and colon contains a vast ecosystem of bacterial 
species, dominated by strict anaerobes which outnumber aerobic bacteria by a factor of 1000 
to 1 .(56) Recent investigations suggest that resident enteric bacteria may have differing 
abilities to induce and perpetuate inflammation in humans and animals. Increased luminal 
concentrations of Bacteroides vulgatus and functionally altered E. coli have been 
incriminated in the pathogenesis of human IBD.(57,58) Bacteroides vulgatus plays an 
essential role in the pathogenesis of carrageenan-induced colitis in guinea pigs(59), while 
sera from spontaneously colitic C3H/HeJBir mice show strong antibody reactivity to 
bacterial antigens from members of the Enterobacteriaceae and Enterococcus spp.(60) 
Furthermore, several species of Helicobacter have been described, (61,62) including H. 
hepaticus (63) and H. bilis, (61,64,65) which have been shown to colonize the liver and 
intestine and elicit IBD in immunodeficient mice and rats.(66) 
These previous studies indicate a theme of host-microbial interactions and genetic 
regulation of host responses to commensal and pathogenic microbial agents. The diversity of 
animal models indicates that multiple genetic defects in immune function and disturbances in 
barrier integrity can lead to pathogenic host responses. Furthermore, these rodent model 
results suggest that each host genetic background may have a dominant bacterial stimulus 
and thus has important implications with regards to designing optimal therapy for individual 
patients. Therefore, it is important to identify which components of the indigenous 
microflora are responsible for the antigen-specific immune responses which contribute to the 
development of colitis. 
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The Brachyspira hyodysenteriae model of intestinal inflammation 
Brachyspira hyodysenteriae is the etiologic agent of swine dysentery, an 
economically important disease of swine. (67-69) Histologic lesions in pigs share similarity 
to those of UC in humans, and include mucosal epithelial erosions, mononuclear 
inflammatory cell infiltration of the lamina propria, and coagulative necrosis of the 
superficial mucosa.(70,71) Putative virulence determinants of B. hyodysenteriae might 
include multiple p-hemolysin(s) and a lipopolysaccharide (LPS) or LPS-like moiety; 
however, the pathogenesis of the disease remains unknown.(72,73) The disease has been 
reproduced in conventional pigs with pure cultures of B. hyodysenteriae (74-76) and in 
gnotobiotic pigs co-infected with certain obligate anaerobic bacteria, including Bacteroides 
fragilis.{77,78). Subsequent studies have demonstrated that B. hyodysenteriae induces gross 
and microscopic lesions similar to those of swine dysentery in the large intestine of mice 
following oral inoculation.(79,80) Furthermore, the presence of synergistic bacteria appears 
to be a prerequisite for B. hyodysenteriae infection to express its pathogenicity in germfree 
pigs (77,81) and mice (77,80,82), suggesting that disease caused by B. hyodysenteriae 
infection may be influenced by the nature of the intestinal flora. 
Gnotobiotic Studies 
The luminal microenviroment may be manipulated by studying germ-free (sterile) 
rodents or ex-germ-free mice and rats colonized with a single (monoassociated) or a 
combination of bacterial species. In these studies, the severity and location of intestinal 
inflammation correlates closely with the magnitude of microbial stimulation.(83) For 
example, IL- 10" " (knockout) mice raised under conventional conditions develop lethal small 
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and large intestinal inflammation.(84) However, specific pathogen free (SPF) mice have 
non-lethal inflammation restricted to the colon; germ-free IL-10"A mice exhibit no clinical, 
histologic, or immunologic evidence of colitis.(85) A similar lack of colitis and gastritis is 
found in germ-free HLA-B27/p 2 -microglobulin transgenic rats. Additionally, gnotobiotic 
B27 transgenic rats colonized with SPF bacteria develop progressively more aggressive 
colitis which becomes statistically significant 4 weeks after colonization. (41) A consistent 
lack of colitis in other germ-free knockout and transgenic murine colitis models studied to 
date and in most induced models indicates the near universal requirement for commensal 
bacteria to induce chronic immune-mediated enterocolitis (Table 4). The acute DSS model is 
the only experimental model to date where the sterile environment does not markedly 
diminish experimental colitis although conflicting results have been reported.(86,87) 
Gnotobiotic studies do show that resident bacterial species have differential capacities 
to induce inflammation and that the dominant bacterial stimuli may depend upon the host 
immunologic (and perhaps genetic) background. Well recognized pro-inflammatory 
bacterial species include Bacteroides vulgatus, Clostridium spp., Enterococcus faecalis, 
certain strains of E. coli, and Helicobacter species. Importantly, the phenotype of disease in 
the same host is different when these different bacterial species are present. Thus, various 
hosts require different bacterial subsets to induce chronic immune-mediated intestinal 
inflammation and illustrate the complexity of interpreting clinical investigations in humans. 
Lastly, host genetic susceptibility and the ability to effectively regulate host responses 
to resident flora contribute to IBD in humans. Polymorphisms in the leucine-rich-repeat 
(LRR) domain of intracellular NOD2/CARD15 are associated with CD.(88,89) This domain 
(which is expressed in normal monocytes, macrophages, and dendritic cells, and in intestinal 
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epithelial cells of IBD patients) binds to LPS and peptidoglycan (especially in Gram negative 
bacteria) to activate the nuclear transcription factor NFKB.(90) The NFKB signaling pathway 
is a key determinant of the inflammatory response (via production of pro-inflammatory 
cytokines such as IL-1(3, TNF, IL-6, and IL-8) and maintenance of mucosal homeostasis. 
Conclusions from animal models 
Animal models have revealed that a variety of alterations in the immune response can 
result in predominant Thl- (53,91,92) or Th2- (33,93) induced intestinal inflammation. The 
recurring themes derived from these models include: (1) chronic inflammation is T 
lymphocyte mediated; (2) defective immunoregulatory or mucosal barrier function can 
induce chronic intestinal inflammation; (3) commensal enteric bacteria provide the constant 
antigenic and adjuvant stimuli driving chronic enterocolitis; (4) host genetic background 
modulates disease activity. Considerable evidence also indicates that abnormal responses to 
antigens in the normal bacterial flora exist suggesting that a break in oral tolerance to these 
microorganisms may be the trigger for chronic intestinal inflammation. This may occur due 
to faulty mechanisms that normally drive and regulate mucosal immunity or because of some 
dysfunction in the epithelial cell barrier that leads to inappropriate penetration of microbial 
antigens. However, the identity and mechanism(s) by which specific bacteria (or their 
products) interact with the host's immune system during development of intestinal disease 
has not been well characterized. Gnotobiotic animals, containing a defined intestinal 
microflora, serve as a useful tool to search for possible microbial provocateurs of chronic 
immune-mediated intestinal inflammation. 
USE OF A NOVEL GNOTOBIOTIC MURINE MODEL OF COLITIS 
The long term goal of this laboratory is to investigate how the composition of the 
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resident enteric microflora contributes to the development of immunologically-mediated 
intestinal disease. The hypothesis of this research is that alterations in the composition of 
the resident enteric microflora will induce host immune responses which modulate the 
development of colitis. In this regard, we propose the use of a novel gnotobiotic mouse 
model in which host immune responses to antigens derived from the resident bacterial flora 
might be measured. 
Development of the B. hyodysenteriae-Challenge Model of Murine Typhlocolitis: 
Our research group has a longstanding interest in the investigation of microbial-host 
interactions; in particular, the utilization of the Brachyspira hyodysenteriae-challenge model 
to study experimentally-induced typhlocolitis in mice. Over the past 13 years, this laboratory 
has published on the immunopathogenesis (73,94,95), comparative effects of spirochete 
infection (96), mouse strain susceptibility (97), histopathological features (98), and disease 
development (99,100) in mice infected with B. hyodysenteriae. Several of these earlier 
investigations deserve additional commentary as they provide key observations concerning 
this unique model of intestinal inflammation. Note to committee: the genus name for the 
causative agent for swine dysentery has gone through several changes (i.e., Treponema—> 
Serpulina —> Brachyspira). The organism is presently placed in the genus Brachyspira. 
Pathogenesis of Treponema hyodysenteriae: induction of interleukin-1 and tumor 
necrosis factor by a treponemal butanol/water extract (endotoxin). Greer JM, 
Wannemuehler MJ. Microb Pathog 1989; 7:279-288. 
The biologic activities of lipopolysaccharide-like (LPS-like, phenol/water extract) 
and endotoxin-like (butanol/water extract) preparations from Brachyspira hyodysenteriae 
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were examined on murine peritoneal exudate cells (PECs). Both extract preparations were 
less toxic than E. coli LPS for murine PECs. The brachyspiral butanol/water extract did 
induce IL-1 and TNF production but at doses 5- and 50-fold higher than that derived from E. 
coli LPS. These data indicate that butanol/water extracts from B. hyodysenteriae are more 
biologically active than the phenol/water extract and that brachyspiral endotoxin may 
contribute to intestinal inflammation by inducing IL-1 and TNF production. 
Susceptibility of inbred mouse strains to infection with Serpulina (Treponema) 
hyodysenteriae. Nibbelink SK, Wannemuehler MJ. Infect Immun 1991; 59:3111-3118. 
Several inbred strains of mice were orally inoculated with Brachyspira 
hyodysenteriae B204 to determine susceptibility to infection. The influence of host genes Ips 
and ity on disease development were also assessed. Different inbred strains exhibited 
different susceptibilities to infection, with the C3H/HeN strain being the most susceptible. 
The ity gene had no apparent effect on susceptibility of infection. These data indicate that 
differences in disease susceptibility between mouse strains exist independent of the Ips locus 
suggesting a possible causal role for the intestinal microflora, or other environmental factors, 
in disease pathogenesis. 
An enhanced murine model for studies of Serpulina (Treponema) hyodysenteriae 
pathogenesis. Nibbelink SK, Wannemuehler MJ. Infect Immun 1992; 60:3433-3436. 
A defined diet was used to increase the susceptibility of mice infected with 
Brachyspira hyodysenteriae. Mice fed the defined diet for 7 to 14 days prior to and during 
the challenge period manifested more severe cecal lesions than did mice maintained on 
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normal rodent chow. The reason for the increase in susceptibility to B. hyodysenteriae 
infection was unclear but the defined diet appeared to enhance cecal colonization by B. 
hyodysenteriae. Subsequent studies (unpublished data) have shown that the diet induces a 
100-1000 fold increase in total cultivable bacteria from the cecum suggesting a contributory 
role for gut flora in lesion development following B. hyodysenteriae challenge. 
A comparison of the morphologic effects of Serpulina hyodysenteriae or its beta-
hemolysin on the murine cecal mucosa. Hutto DL, Wannemuehler MJ. Vet Pathol 1999; 
36:412-422. 
Morphologic changes in the ceca of mice infected with either B. hyodysenteriae or 
exposed to ^-hemolysin were compared. Macroscopic lesions were first apparent at 14 hours 
post-infection while ultrastructurally, luminal bacteria were translocated through epithelial 
cells into the lamina propria. In other experiments, the placement of purified B. 
hyodysenteriae hemolysin into surgically closed murine ceca resulted in similar 
ultrastructural changes as seen with B. hyodysenteriae inoculation. Thus, the ^-hemolysin of 
B. hyodysenteriae causes the same early morphologic changes in the cecal mucosa of mice as 
are present in mice infected with the organism itself. Based on the observed bacterial 
translocation, luminal bacteria also appear to play a unique role in lesion development in this 
model. 
We have since extended these earlier observations to show that the use of antibiotic 
therapy to selectively deplete members of the microflora (e.g., gram negative anaerobes) 
abolishes the ability of B. hyodysenteriae to induce colitis.(lOl) It is apparent from these 
investigations that the singular presence of B. hyodysenteriae in murine ceca is 
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insufficient to cause disease, and that enteric bacteria are necessary for the 
development of intestinal inflammation. Apparently, the indigenous flora provides the 
necessary antigenic or phlogistic stimulation to induce colitis in affected mice. Preliminary 
data indicate that B. hyodysenteriae-mfected mice develop a polarized Thl immune response 
characterized by prominent IgG2a production and IFN-y secretion. (102) In addition, 
evaluation of inflamed ceca has demonstrated that a spiral shaped bacterium significantly 
invades the mucosa (18-24 hours post-infection) following infection with B. hyodysenteriae. 
This translocated bacterium has similar morphologic features to Helicobacter spp. on the 
basis of electron micrographs (103) (Figure 2). Analysis by polymerase chain reaction 
(PGR) techniques hffas confirmed the presence of Helicobacter spp. in cecal specimens 
obtained from similarly infected mice. These accumulated preliminary data strongly 
incriminate normal flora (including Helicobacter spp.) in the pathogenesis of intestinal 
inflammation in conventional mice infected with B. hyodysenteriae. 
Figure 2. (A) Electron photomicrograph of helicobacter-like organisms in the lumen of the 
mouse cecum. (B) Photomicrograph of the murine cecum obtained 24 hours following 
challenge with B. hyodysenteriae depicting multiple helicobacter-like organisms (arrows) 
within mucosal epithelial cells. Images from Hutto DL, Wannemuehler MJ. A comparison of 
the morphologic effects of Serpulina hyodysenteriae or its beta-hemolysin on the murine 
cecal mucosa. Vet Pathol 1999; 36:412-422. 
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In subsequent studies, we have enhanced this model to characterize antigen-specific 
immune responses to a defined gastrointestinal flora in the pathogenesis of experimental 
colitis. Our current model utilizes gnotobiotic C3H mice harboring an altered schaedler flora 
(consisting of eight anaerobic organisms) which are orally infected with B. hyodysenteriae. 
Preliminary results indicate that the onset of disease is slower and lesion severity is less in 
gnotobiotic mice in comparison to C3H mice with a complex, conventional flora. 
Additionally, the introduction of a non-resident bacterium, such as Helicobacter bilis, into 
this model alters the immunological responses and lesion severity of these gnotobiotic mice 
subsequent to the onset of colitis. These data indicate that the nature of the gastrointestinal 
flora significantly influences the immunological bias of the host immune response 
modulating the severity of colitis. 
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ABSTRACT 
Background: Previous investigations from this laboratory have shown that infection of C3H 
strain mice with Brachyspira hyodysenteriae induces a typhlocolitis with features that are 
similar to ulcerative colitis. The immunological response of these conventional C3H/HeOuJ 
mice has been shown to be a predominant Thl-like response (e.g., antigen-specific IgG2a 
responses and IFN-y responses). While the spirochetal pathogen initiates the onset of 
disease, this model of bacterial-induced colitis has been shown to be dependent upon the 
nature of the resident bacterial flora and the host's inflammatory response. Aim: To 
characterize antigen-specific immune responses to a defined gastrointestinal flora in the 
pathogenesis of experimental colitis. Methods: Gnotobiotic C3H/HeN mice possessing an 
altered schaedler flora (8 separate organisms) were used to evaluate the host's response 
following challenge with B. hyodysenteriae. Immunologic parameters evaluated included 
altered cecal morphology, histologic lesion severity scores, isotype of the antigen-specific 
serum antibody (ELISA), and antigen-induced cytokine responses. Results: Results indicate 
that the onset of disease is slower and lesion severity is less in the gnotobiotic mice in 
comparison to C3H mice with a complex, conventional flora. The immunologic response of 
the gnotobiotic mice subsequent to onset of disease was of mixed Thl :Th2 phenotype, but 
predominantly Th2-like. Because the conventional colony of C3H mice was colonized with 
Helicobacter species, we co-infected the gnotobiotic C3H mice with H. bilis to assess the 
influence of Helicobacters on the severity of disease and the bias of the immune response. 
Results indicate that colonization of the gnotobiotic C3H mice with H. bilis did enhance the 
severity of the colonic lesions but that the immune response was shown to be Th2-like. 
Conclusions: These data indicate that the nature of the gastrointestinal flora significantly 
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influences the immunologie bias of the immune response and the presence of Helicobacter 
species do not apriori predispose toward a Thl immune response. The B. hyodysenteriae 
challenge model provides reproducible typhlocolitis quickly and consistently in 
immunocompetent mice and can be used to assess the host's immune response following 
onset of colitis. 
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Introduction 
Aberrant or exaggerated immune responses to bacterial antigens derived from the 
intestinal lumen are thought to serve as the initiating events leading to the development of 
inflammatory bowel disease (IBD).1 For example, humans who express the HLA-B27 
haplotype are known to be predisposed to colitis.2 The recent observation that germfree, 
HLA-B27 transgenic rats fail to develop colitis suggests that host immunologic responses to 
bacterial antigens derived from the intestinal microflora are a part of the pathogenic 
mechanism.3,4 The importance of immune responsiveness to normal bacterial antigens in the 
pathogenesis of disease has additionally been demonstrated using genetically manipulated 
(i.e., knock-out) mice (e.g., IL-2-, IL-10-, T-cell receptor-a deficient mice).1 Collectively, 
these and other observations support the hypothesis that unregulated or inappropriate 
responses to normal resident microflora may dictate the initiation or perpetuation of chronic 
intestinal inflammation as much as, or even more than, predisposing genetic factors. This 
contention is supported by observations that genetic disruptions in the immune response are 
not pathognomonic in themselves as is demonstrated when these mice are reared under 
gnotobiotic or specific-pathogen free (SPF) conditions.3,5,6 In addition, humans with IBD 
and experimental models with IBD enter a period of remission following antibiotic 
therapy.1,7"11 However, the unequivocal endorsement of this concept has been clouded by the 
use of experimental models relying on spontaneous development, as well as, difficulties in 
ascertaining whether the observed colitis has been directly mediated by acute inflammatory 
responses or acquired immune responses. In order to distinguish between these possibilities, 
a predictable and highly reproducible model by which microbial-induced inflammation can 
be initiated and examined is needed. 
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Previously, we have shown that infection of C3H mice with Brachyspira 
hyodysenteriae induces a typhlocolitis with features that are similar to ulcerative colitis.12'13 
The immunological response of these conventional C3H/HeOuJ mice was shown to be 
predominantly Thl-like (e.g., antigen-specific IgG2a and IFN-y responses). While the 
spirochete, B. hyodysenteriae, initiates the onset of disease, this model of bacterial-induced 
colitis is dependent upon the nature of the resident bacterial flora and the host's inflammatory 
response.14 In addition, evaluation of inflamed ceca has demonstrated that a spiral shaped 
bacterium significantly invades the mucosa (18-24 hours post-infection) following infection 
with B. hyodysenteriae}2 In subsequent studies, we have utilized electron microscopy and 
polymerase chain reaction (PGR) techniques to confirm that the translocated bacteria are 
Helicobacters.15 These accumulated preliminary data strongly incriminate the normal 
microflora (including Helicobacter spp.) in the pathogenesis of intestinal inflammation in 
conventional mice infected with B. hyodysenteriae. 
To better understand the nature of microbial populations inciting intestinal 
inflammation, we first infected gnotobiotic C3H mice (harboring an altered schaedler flora 
composed of eight separate organisms) with H. bilis followed by co-infection 3 weeks later 
with B. hyodysenteriae. We addressed the hypothesis that alterations of the resident 
microflora modulate the susceptibility to the development of experimental colitis. Results 
indicate that the onset of disease is slower and lesion severity is significantly less in 
gnotobiotic mice in comparison to C3H mice with a complex, conventional flora. Moreover, 
the introduction of a non-resident bacterium, such as H. bilis, into this model system alters 
the immunological responses and lesion severity of these gnotobiotic mice subsequent to the 
onset of colitis. These observations indicate that the composition of the enteric microflora 
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influences the immunological bias of the host response to luminal bacteria and mediates the 
intensity of colitis. 
Materials and Methods 
Animals. Four- to eight-week old gnotobiotic reared C3H/HeN mice (mostly female) were 
obtained from Taconic Farms (Gerrnantown, N.Y.). The gnotobiotic mice were colonized 
with an altered schaedler flora (ASF) consisting of eight anaerobic bacteria (Table l).16 
Gnotobiotic mice were housed in Trexler plastic isolators under sterile conditions and fed an 
irradiated diet (e.g., Harlan-Teklad) and autoclaved water for the duration of the project. All 
mice were certified free of Helicobacter spp. by the vendor and re-tested on-site prior to 
study enrollment. All manipulations performed on mice were approved by the Iowa State 
University Committee on Animal Care. 
Taxon Strain 
Lactobacillus acidophilus ASF 360 
Lactobacillus animalis ASF 361 
Bacteroides distasonis ASF 519 
Flexistipes phylum ASF 457 
Clostridium cluster XIV ASF 356 
Eubacterium plexicaudatum ASF 492 
Low G + C-content spp. ASF 500 
Clostridium cluster XIV ASF 502 
Table 1. Bacterial members comprising the altered schaedler flora (ASF). 
Treatment Groups and Study Design. Gnotobiotic mice were assigned to one of four 
treatment groups on the basis of H. bilis infection and B. hyodysenteriae inoculation as 
follows: Group 1 (control) - no infection; Grdup 2 - infected with B. hyodysenteriae alone; 
Group 3 - infected with H. bilis alone; Group 4 - dual-infected with H. bilis and with B. 
39 
hyodysenteriae. Representative experimental and control mice were euthanized by CO? 
asphyxiation on B. hyodysenteriae post-infection day 21, with samples processed for gross 
lesions, bacteriology, histopathology, antigen-specific serum IgG isotype concentrations, and 
levels of cytokines secreted from antigen stimulated cells. 
Bacterial Inoculation. Mice were orally infected with a bacterial inoculum (0.3 ml, 
approximately 108-109 CFU/ml) of H. bilis (ATCC strain 51630) administered every other 
day for three doses. Dual-infected mice received the H. bilis inoculum 3 weeks prior to 
challenge with B. hyodysenteriae. Confirmation of H. bilis infection post-inoculum was 
made by PCR evaluation of feces or cecal contents and culture. Dual-infected mice were 
inoculated with 108 CFU/ml B. hyodysenteriae organisms given by orogastric 
intubation.13'17'18 Previous experiments utilizing conventional C3H mice had indicated that 
characteristic histological lesions were evident 72 to 96 hours post-inoculation, with the 
spirochete infection confirmed at necropsy by demonstration of organisms grown on 
selective media.19 
Helicobacter bilis and ASF-Specific PCR. Fecal samples or cecal contents were analyzed 
for Helicobacter spp and H. bilis as described previously.20'21 For generic Helicobacter PCR, 
5jo,l of quantitated fecal DNA was used as template while for H. bilis PCR, IOJJLI of 
quantitated fecal DNA was used as template for all samples. Terminal confirmation of ASF 
colonization was performed by PCR of fecal pellet DNA from defined flora mice using ASF-
specific primers16, with modifications made to some primer sequences and the PCR 
conditions. 
Bacterial Antigens. The H. bilis organisms were cultivated in Columbia broth and the 
bacteria were harvested by centrifugation. The cells were washed with sterile PBS, the cell 
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pellet was frozen, cells were lyophilized, and then stored at -20° C until used. Brachyspira 
hyodysenteriae B204 was grown anaerobically in trypticase soy broth supplemented with 2 
% horse serum. Cells were grown overnight and harvested by centrifugation. Subsequently, 
cells were washed with buffer, lyophilized, and stored at -20° C until further use. Each 
member of the altered schaedler flora (ASF 356, ASF 360, ASF 361, ASF 457, ASF 492, 
ASF 500, ASF 502, and ASF 519) was grown in anaerobically prepared medium and 
cultured at 37°C for five to seven days. Cells were grown in either reinforced Clostridium 
medium (RCM) supplemented with 5 % calf serum (ASF 360, ASF 361, ASF 356, ASF 502, 
and ASF 519) or schaedler broth supplemented with 5 % sheep serum (ASF 457, ASF 492, 
and ASF 500). Because many of these organisms are extremely oxygen sensitive (EOS), all 
inoculations were performed in a Coy anaerobic chamber. Culture flasks were sealed in 
anaerobic jars and then placed in an incubator. As above, the cells were harvested from broth 
by centrifugation, washed in PBS, and lyophilized. 
Bacterial antigens (e.g., H. bilis, B. hyodysenteriae, and all eight ASF strains) 
used for ELISA or for stimulation of lymphocyte cultures were prepared from the lyophilized 
cells. Briefly, cells were weighed and resuspended in buffer or tissue culture medium to a 
final concentration of 2 mg/mL (dry weight to volume). The cell suspension was then placed 
on ice and sonicated for 5 minutes to prepare whole cell sonicates (WCS). Sonication was 
performed using 30 second pulses to prevent the suspension from overheating (i.e., 
denaturing of the proteins). Cell disruption was monitored microscopically. Protein content 
was determined by BCA analysis per manufacturer's instructions (Pierce Laboratories). For 
the preparation of antigen for in vitro stimulation of lymphocytes, the WCS were sterilized 
by UV light. Additionally, sterility was confirmed by bacteriological methods (e.g., aerobic 
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and anaerobic blood agar cultures). These methods were used to prepare all antigens used for 
these studies. In order to ensure that all studies were performed with the same lot of 
antigens, each of the bacterial species to be used was grown during the first six months of the 
project to provide sufficient antigenic mass to complete these experiments. 
Gross Pathology. Macroscopic cecal lesions were scored using previous published 
criteria.13 Briefly, ceca were evaluated macroscopically for atrophy, edema, and/or increased 
mucus in the ingesta, and given a gross lesion score (range 0-3:0 = normal, 3 = severe cecal 
lesion). Representative tissue sections were fixed in neutral buffered 10% formalin for 
histopathologic evaluation. 
Histology. Formalin-fixed cecal tissues were embedded in paraffin, sectioned at 5 pm, and 
stained with hematoxylin and eosin (H&E) for assessment of inflammation. Tissue sections 
were coded to blind the pathologist (J Hostetter, Dept. of Veterinary Pathology) to the 
infection status of the animal. The cecal tissue sections from each mouse were scored on 
severity of mucosal epithelial damage, architectural/glandular alterations, and 
magnitude/character of lamina propria cellular infiltrate (Table 2). 
42 
Table 2. Scoring System for Histopathological Evaluation of 
Gastrointestinal Inflammation 
Parameters Scoring Criteria 
LP immune cells 
Mucosal height Ratio of crypt depth to width Rising score from 1-5 (mild-*severe hyperplasia) 
Lymphocytes/plasma cells are the expected population 
Mixed inflammation = increased neutrophils 
Erosions 
Edema score 
Inflammatory score Denotes quantity of cellular infiltrates in the LP Rising score from 1 -5 (normal -*• severe inflammation with necrosis 
Rising score from 1-5 (1 = mild edema; 5 = severe edema with 
architectural distortion) 
Other Submucosal lymphoid hyperplasia (present of absent) 
Table 2. Scoring system for the histopathological evaluation of gastrointestinal 
inflammation. LP = lamina propria. 
Antigen-Specific Serum Antibodies. Blood samples were obtained via cardiac puncture at 
the same time tissues were collected for analysis. Resulting sera samples were stored at -20° 
C until assays were performed. Determination of H. bilis-, B. hyodysenteriae-, and ASF-
specific antibodies in sera was performed by ELISA as previously described.22 Briefly, 96-
well microliter plates (Immunlon H) were coated with sonicated whole cell lysates of each of 
the eight anaerobic bacteria comprising the altered schaedler flora, H. bilis, and B. 
hyodysenteriae. Diluted serum (1:200) was added to each well and incubated at 4°C 
overnight. Then, alkaline phosphatase conjugated goat anti-mouse IgGl or IgG2a was added 
and incubated for 1 hour at room temperature. Wells were colorimetrically developed using 
p-nitrophenyl phosphate at room temperature. Optical densities were measured at 405 nm 
using a microplate reader. 
Cytokine Analysis by Multiplexed Flow Cytometric Assay. Lymphocytes isolated from 
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the spleen and mesenteric lymph nodes were incubated at 2.5 x 106 cells/ml with or without 
whole cell lysates of the ASF organisms, H. bilis, and B. hyodysenteriae for 72 hours. Cell 
cultures were treated with concanavalin A to evaluate the overall nature of the T cell 
response. Cell-free supematants were harvested and analyzed for their concentration of Thl 
(TNF-a, IFN-y, IL-2, IL-12) and Th2 (IL-4, IL-10) cytokines using a multiplexed flow 
cytometric assay (The FlowMetric™ System, Luminex, Austin, TX). Cytokine 
concentrations were measured using a murine cytokine detection kit (Mouse Cytokine 
LINCOplex Kit, Linco Research, St. Charles, MO) specifically designed for use with the 
Luminex systems. 
Data Analysis. All data are expressed as mean + SEM with values derived from 3 
independent experiments. For all analyses, non-parametric assays were utilized with a 
P<0.05 considered significant. 
Results 
Colonization with H. bilis, B. hyodysenteriae, and ASF bacteria 
Mice inoculated with H. bilis became positive by fecal PCR 12-14 days post­
infection. Both Helicobacter genus and H. Mw-specific primers consistently detected 
infection under optimal conditions. In some instances, culture of cecal contents at necropsy 
was also used to confirm colonization with Helicobacter spp. Fecal samples recovered from 
uninfected control animals remained PCR negative for H. bilis. Confirmation of infection 
with B. hyodysenteriae was made from feces collected from infected mice, with the organism 
subsequently grown on selective media. Specific PCR products for members of the ASF 
(with the exception of that derived from ASF member 360) were reliably obtained by 
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amplification of feces or cecal contents obtained at necropsy from defined flora mice using 
the ASF-specific primers in a multiplex format (data not shown).16 
Gnotobiotic mice develop typhlocolitis of varying severity subsequent to colonization by 
H. bilis and B. hyodysenteriae 
Clinical signs of colitis (e.g., diarrhea) were variably observed in dual-infected 
defined flora (DP) mice and those colonized with B. hyodysenteriae alone. Cecal scores 
from these groups were significantly ÇP<0.05) increased as compared to scores in defined 
flora and H. bilis-infected groups (Table 3). Grossly, diseased ceca had thickened cecal 
walls and contained pasty contents. In contrast, H. bilis-infected mice had only mild 
inflammation characterized by cecal involution and local mesenteric lymphadenopathy. 
Control mice had no detectable lesions. 
Treatment group Cecal score Comment 
Defined flora 
H. bilis infected 
B. hyodysenteriae 
infected 
Dual infected 
0.2 t .08 
1.4 +0.la 
1.4 +0.1 
Grossly normal 
Ceca slightly smaller 
Mesentric lymphadenopathy 
Modei ato • marked .edema 
' 
Small ceca / mucoid contents 
Moderate edema 
Table 3. Gross pathological scores of gnotobiotic mice infected with or without H. bilis or 
B. hyodysenteriae. Numbers reflect mean scores + SEM derived from 6-8 mice per treatment 
group averaged over 3 independent experiments. Maximum score is 3.0 (See Methods for 
scoring criteria). aP<0.05 versus defined flora and H. Mz's-infected mice. 
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Similar to the gross observations, histologic lesions in dual-infected DF mice and 
mice infected with B. hyodysenteriae were significantly (P<0.05) increased over controls and 
H. bilis-infected littermates (Table 4). Cecal inflammation in H. bilis-infected mice was 
characterized by predominantly mononuclear infiltration of the lamina propria (LP) with 
scattered foci of neutrophils. A similar but more intense infiltrate (accompanied by increased 
mucosal edema) was observed in B. hyodysenteriae-infected DF mice (Figure 1, panel C). 
Cecal tissues from dual-infected DF mice showed slightly more inflammation than B. 
hyodysenteriae-mfected mice, with even greater LP cellular infiltrate, increased mucosal 
height, crypt hyperplasia, and mucosal edema (Figure 1, panel D). Tissue sections of ceca 
from non-infected control mice were histologically normal. 
Intestinal colonization Histologic score3 
Defined flora 3.6 +0.1 
H. bilis 5.6 + 0.1b 
B. hyodysenteriae 9.0 + 0.2' 
Dual infected 9.3+0.3 c 
Table 4. Histopathological scores in gnotobiotic mice infected with and without H. bilis or 
B. hyodysenteriae. Numbers reflect mean scores + SEM derived from 6-8 mice per treatment 
group averaged over 3 independent experiments. 
a Maximum value for each parameter except that assigned to inflammatory cells is 5, and 
maximum total histology score is 20. 
b P<0.05 for H. bilis versus defined flora and B. hyodysenteriae or dual infected. 
c P<0.05 for B. hyodysenteriae or dual versus H. bilis and defined flora. 
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C D 
Figure 1. Histological changes in the cecal mucosa of defined flora mice after bacterial 
infection. (A) Controls - no infection; (B) Mice infected with H. bilis alone; (C) Mice 
infected with B. hyodysenteriae alone. Note the severe mucosal edema, cellular infiltrate, and 
diffuse epithelial erosions; (D) Mice infected with both H. bilis and B. hyodysenteriae. All 
images (160X) at Pi-day 42. 
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Gnotobiotic mice develop antigen-specific IgGl/IgG2a responses to the resident 
microflora following colonization with H. bilis and B. hyodysenteriae 
Elevated serum concentrations of IgGland IgG2a antibodies directed against 
specific members of the ASF were observed in DF mice colonized with either novel 
bacterium, and these responses were greatest in H. Mzs-infected mice (Figure 2A). The 
evaluation of pooled antibody responses revealed significant group differences in IgG isotype 
levels directed at antigens derived from members of the resident flora (Figure 2A). For 
IgGl, all colonization groups evoked significantly (P<0.05) increased anti-//. bilis antibody 
responses compared to control mice, with the greatest response observed in H. bilis-infected 
mice (Figure 2B). Similarly, both H. bilis and dual infected mice had significantly (P<0.05) 
increased IgG2a responses directed against H. bilis antigen when compared to B. 
hyodysenteriae-mfected mice and non-infected controls (Figure 2B). 
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Figure 2A. Antibody responses to antigens derived from members of the altered schaedler 
flora (ASF). Serum was collected from gnotobiotic mice 21 days following challenge with 
B. hyodysenteriae. The serum samples from individual mice were diluted (1:200) and 
analyzed individually by ELIS A using sonicated whole cells of ASF bacteria as antigen. 
Numbers reflect means + SEM of the optical density (absorbance) for each treatment group. 
Each mean value comprises triplicate wells of individual mouse serum from 4-8 mice per 
treatment group averaged over 3 independent experiments. The control group consisted of 
gnotobiotic mice colonized with the 8 organisms comprising the ASF; the H. bilis group was 
infected with H. bilis on day -21; the B. hyodysenteriae group were gnotobiotic mice 
colonized with B. hyodysenteriae on day 0; and the dual-infected group were mice infected 
with both H. bilis (day -21) and B. hyodysenteriae (day 0). ASF 356 = Clostridium cluster 
XIV; ASF 360 = Lactobacillus acidophilus; ASF 361 = Lactobacillus animalis; ASF 457 = 
Flexistipes phylum; ASF 492 = Eubacterium plexicaudatum; ASF 500 = Low G + C-content 
spp.; ASF 502 = Clostridium cluster XIV; ASF 519 = Bacteroides distasonis. 
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Figure 2B. Pooled antibody responses to antigens of the altered schaedler flora (ASF). 
Serum was collected from gnotobiotic mice 21 days following challenge with B. 
hyodysenteriae. The serum samples from individual mice were diluted (1:200) and analyzed 
individually by ELIS A using sonicated whole cells of ASF bacteria as antigen. Numbers 
reflect means + SEM of the pooled optical density (absorbance) for all 8 ASF antigens 
averaged over 3 independent experiments. The control group consisted of gnotobiotic mice 
colonized with the 8 organisms comprising the ASF; the H. bilis group was infected with H. 
bilis on day -21; the B. hyodysenteriae group were gnotobiotic mice colonized with B. 
hyodysenteriae on day 0; and the dual-infected group were mice infected with both H. bilis 
(day -21) and B. hyodysenteriae (day 0). ASF 356 = Clostridium cluster XIV; ASF 360 = 
Lactobacillus acidophilus; ASF 361 = Lactobacillus animalis; ASF 457 = Flexistipes 
phylum; ASF 492 = Eubacterium plexicaudatunv, ASF 500 = Low G + C-content spp.; ASF 
502 = Clostridium cluster XIV; ASF 519 = Bacteroides distasonis. Statistical inferences are 
noted under each histogram in Figure 2B. 
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Colonization of gnotobiotic mice with H. bilis or B. hyodysenteriae evokes 
compartmentalized cytokine responses to members of the resident microflora 
Cytokine responses in lymphocyte culture supernatants from the spleen (SPL) and 
mesenteric lymph nodes (MLN) were compartmentalized in their magnitude and varied 
between treatment groups (Figure 3A). Responses in SPL supernatants were greatest for IL-
4 and IL-10 while IFN-y responses were greater in MLN cultures. When analysis of pooled 
cytokine réponses was performed, significant (P<0.05) differences between groups were 
observed for all cytokines in both SPL and MLN cultures (Figure 3B). The details of these 
inferences are included under each histogram of Figure 3B. Supernatants derived from 
lymphocyte cultures from non-infected DF mice showed minimal but detectable levels 
(pg/ml) of IFN-y, IL-4, and IL-10. 
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Figure 3A. Detection of cytokine production to individual ASF antigens in culture supernatant fluid 
from splenocytes (SPL) or mesenteric lymph node (MLN) cells. Lymphocytes recovered from mice 
in each of four treatment groups were cultured in the presence of specific antigens (25 ng/mL) or 
concanavalin A (5 pg/mL) for 72 hrs and harvested for analysis. Undiluted supernatant fluid was 
analyzed by multiplexed flow cytometric assay for the amount of IFN-y, IL-10 or IL-4. Data 
represent means + SEM of cytokine concentration (pg/ml) derived from 3 independent experiments. 
360 = Lactobacillus acidophilus; 492 = Eubacterium plexicaudatum; 500 = Low G + C-content 
species; 502 = Clostridium cluster XIV; 519 = Bacteroides distasonis; H. bilis = Helicobacter bilis; 
B. hyo = Brachyspira hyodysenteriae B204. 
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Figure 3B. Detection of pooled cytokine responses to ASF antigens per group in culture 
supernatant fluid from splenocytes (SPL) or mesenteric lymph node (MLN) cells following 
antigenic stimulation. Lymphocytes recovered from mice in each of four treatment groups 
were cultured in the presence of specific ASF antigens (25 jig/mL) for 72 hours and 
harvested for analysis. Undiluted supernatant fluid was analyzed by multiplexed flow 
cytometric assay for the amount of IFN-y, IL-10 or IL-4. Data represent means + SEM of the 
pooled cytokine concentrations (pg/ml) to all 8 ASF antigens per group derived from 3 
independent experiments. Statistical inferences are noted under each histogram in Figure 3B. 
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Discussion 
The B. hyodysenteriae-challenge model of colitis is unique and differs from most 
other mouse models. Its distinct advantages include (a) the initiating etiologic agent (B. 
hyodysenteriae) is known; (b) a defined bacterial flora (gnotobiotic or conventional) is 
necessary to develop intestinal inflammation; (c) this model provides reproducible 
typhlocolitis quickly and consistently allowing temporal studies to be performed; and (d) 
immunocompetent mice are used to assess the host's immune response following onset of 
colitis. We have previously reported on the strain-related differential susceptibility in 
conventional mice to B. hyodysenteriae infection and on the use of a defined diet to enhance 
the susceptibility of mice to the pathogenic effects of the spirochete infection.13'17 We have 
since extended these observations to show that the use of antibiotic therapy to selectively 
deplete members of the microflora (e.g., gram negative anaerobes) abolishes the ability of B. 
hyodysenteriae to induce colitis.13,23 It is apparent from these investigations that the singular 
presence of B. hyodysenteriae in murine ceca is insufficient to cause disease, and that enteric 
bacteria are necessary for the development of intestinal inflammation. Apparently, the 
indiginous flora provides the necessary antigenic or phlogistic stimulation to induce colitis in 
affected mice. 
Previous studies demonstrate a crucial role for resident bacteria in the 
pathogenesis of experimental colitis and inflammatory bowel disease (IBD) in humans.1,24,25 
Both spontaneous and induced inflammation in a diverse range of rodent models have been 
associated with commensal resident bacteria.3,6,26"35 Determining the nature of those 
microbial populations that are responsible for the initiation and perpetuation of colitis is 
difficult given the complex microbial environment present in most models. Importantly, not 
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all luminal bacteria have equivalent abilities to induce inflammation. Bacteroides vulgatus 
induces colitis in carrageenan-fed guinea pigs32 and HLA-B27 transgenic rats3,36 and induces 
a comparable degree of colitis in monoassociated HLA-B27 transgenic rats to lesions 
observed in transgenic rats colonized with six bacterial species (including B. vulgatus)?6 
Both HLA-B27 transgenic rats monoassociated with E. coli and IL-10"7" mice 
monoassociated with B. vulgatus, Helicobacter hepaticus, Clostridium sordelii or viridans-
type streptococci fail to develop colitis.37'38 On the other hand, Enterococcus faecalis induces 
IBD in IL-10"7" mice.39 Thus different bacteria and/or their products are required to evoke 
chronic immune-mediated inflammation in various susceptible hosts. 
The gnotobiotic mouse model is a useful tool for evaluating the roles of bacterial 
species in the development of intestinal inflammation. Our rationale was that the use of an 
available defined flora mouse model that is more complex, and seemingly more realistic, 
than monoassociated models would assist in the study of microbially-triggered host 
responses that predispose to or mediate intestinal inflammation.16 We chose to introduce H. 
bilis into the B. hyodysenteriae-challenge model as a novel non-resident bacterium (e.g., 
provocateur), based on its role as a potential pathogen in conventional mice infected with B. 
hyodysenteriae and based on the association of Helicobacter spp. with IBD in other rodent 
models.35'40"44 It was anticipated that intestinal inflammation would be mediated by a pro­
inflammatory Thl immune response (based on previous studies in conventional flora mice 
colonized with B. hyodysenteriae) directed at members of the resident microflora, and that 
this response would be potentiated following the introduction of H. bilis. While we did 
observe modest increases in gross/histologic inflammatory indices in dual-infected mice, the 
ability of H. bilis infection to modulate immunologic responses (e.g., to a balanced Thl :Th2 
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profile) to resident microflora at a single time point was an unexpected finding. This 
observation suggests that the introduction of a previously non-resident bacterium may alter 
the homeostatic balance of the commensal flora and evoke antigen-specific responses 
capable of inciting an inflammatory response in a susceptible host. 
Some earlier studies suggest that infection with some Helicobacter species evokes 
Thl-mediated chronic gastrointestinal inflammation.45"47 In the present study, the profile of 
antibody and cytokine responses to antigens derived from the resident flora were of mixed 
Thl :Th2 expression, but with Th2 responses predominating in the Helicobacter groups. We 
observed only mild gross and histologic lesions in H. bilis-infected mice while more severe 
colitis was seen in B. hyodysenteriae- and dual-infected mice. While these observations 
demonstrate that B. hyodysenteriae can induce cecal inflammation in gnotobiotic mice, they 
also suggest that additional bacterial interactions (e.g., introduction of H. bilis into the 
intestinal microflora) contribute to the genesis of host immunologic responses.3 We 
hypothesize that colonization with H. bilis perturbed the local microecology and influenced 
the immunological bias of the host response to luminal bacteria (i.e., broke tolerance or 
overcame immunological ignorance). In turn, these protective Th2 responses generated 
against commensal members, as a consequence of H. bilis colonization, mitigated lesion 
severity in dual-infected mice by apposing the pro-inflammatory (e.g., Thl-like) responses 
characteristic of B. hyodysenteriae infection alone. 
The profile of antibodies and cytokines in gnotobiotic mice having different 
compositions of resident microflora suggest that subpopulations of luminal bacteria exert a 
dominant influence on the induction of subsequent immune responses. Elevated serum levels 
of IgGl and IgG2a to diverse ASF members (in particular ASF356, ASF360, ASF457) were 
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observed in H. bilis-, B. hyodysenteriae-, and dual-infected groups, with the greater antibody 
responses seen in H. Mis-infected mice. Increased concentrations of IgG directed against 
luminal commensal bacteria have been reported in several different animal models of 
colitis.6'48"50 Defined flora mice colonized with H. bilis produced greater serum IgGl and 
IgG2a antibody responses to H. bilis (relative to the responses to the 8 ASF) similar to that 
described in other Helicobacter-associated IBD models.35'51 Induction of antigen-specific 
secretion of IL-4, IL-10 and IFN-y were differentially present in lymphocyte cultures of 
gnotobiotic mice. Relative to non-infected control mice, we observed increased Thl/Th2 
cytokine concentrations between the different mouse groups with B. hyodysenteriae- and 
dual-infected mice evoking the greatest cytokine responses. 
The compartmentalized Th2-like cytokine responses present in dual-infected 
mice, characterized by increased IL-4 and IL-10 in splenic cultures but decreased IFN-y in 
MLN cultures are noteworthy, especially when these results are compared to those findings 
in B. hyodysenteriae-infected mice. Maggio-Price et al35 have recently reported decreased 
IFN-y transcripts in colonic tissues of H. hepaticus-mîecXeà mdr la" "mice having mild 
lesions of IBD. The decreased IFN-y secretion in dual-infected mice was surprising but may 
be attributable to the effects of H. bilis infection which may down-regulate this pro­
inflammatory cytokine and lessen its role in promoting colitis in a susceptible murine host.35 
In keeping with this Th2 profile of cytokines, we found that spleen cells recovered from dual-
infected mice also secreted greater concentrations of IL-10 following antigenic stimulation 
than cells recovered from the other three groups of mice. Cecal bacterial lysates or LPS may 
induce high concentrations of IL-10 by murine mesenteric lymph node cells or splenocytes 
with most being produced by macrophages or dendritic cells.52 IL-10 is an important 
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cytokine in modulating inflammatory responses in IBD, likely through T regulatory cells 
(Trl) and also by B cells and dendritic cells.35,53"56 The anti-inflammatory actions of IL-10 
include inhibition of antigen-specific proliferation and cytokine production by Thl 
lymphocytes and down regulatory effects on antigen presenting cells via suppression of 
macrophage activation and IL-12 production.56"59 Kullberg et al45 showed that CD4+ T cells 
from H. hepaticus-mfected wildtype mice could prevent colitis in Rag" " mice when co-
transferred with CD4+ T cells from H. hepaticus-colonized IL-10"7" mice; and that this 
antigen-specific protection was mediated through the secretion of IL-10. However, IL-10 
may have diverse roles in mediating Helicobacter-indaced inflammation since increased IL-
10 levels accompany severe IBD in mdr la"7" mice with or without H. bilis infection but 
levels are not increased in H. hepaticus-infected mdr la"7" having delayed IBD 
development.35 
These results indicate that perturbation of the microflora may evoke antigen-
specific immune responses to nonpathogenic bacteria but they do not completely explain 
those bacterial components responsible for host responses. Both adjuvants and antigens 
derived from commensal enteric bacteria may stimulate cell-mediated immune responses. 
Luminal bacteria produce several non-viable bacterial products (e.g., LPS1 [from Gram-
negative bacteria], peptidoglycan-polysaccharide (PG-PS) complexes60 [from both Gram-
positive and Gram-negative bacteria], and bacterial DNA61 [containing CpG motifs]) which 
can stimulate innate immunity through pattern recognition receptors, especially toll-like 
receptors (TLR).62"64 Bacterial flagellin, an immunodominant antigen present in several ASF 
bacteria (ASF502, ASF492) as well as flagellin from some Treponema spp., may also 
stimulate pathogenic intestinal immune reactions through TLR 5.65 Serum and mucosal 
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antibody responses likely indicate increased mucosal permeability and/or enhanced 
immunologic responsiveness to multiple resident species.1 Increased levels of inflammatory 
cytokines, such as IFN-y, may also impair epithelial barrier integrity and contribute to 
mucosal inflammation.6 Furthermore, Helicobacter spp. infection may initiate the 
development of intestinal inflammation through diverse mechanisms including the 
elaboration of specific toxins (e.g., cytolethal distending toxins66), IFN-y -mediated 
compromise of intestinal epithelial barrier function35'67, the production of commensal-
specific CD4+ T cells27, LPS-mediated activation of innate immunity through TLR46, and/or 
altered epithelial cell gene expression. It is likely that host responses to commensal luminal 
bacteria are quite heterogeneous and that numerous mechanisms contribute to intestinal 
inflammation. 
In summary, our study describes the use of a gnotobiotic model to investigate 
the nature of microbial populations inciting intestinal inflammation. The introduction of a 
novel bacterium (H. bilis and/or B. hyodysenteriae) perturbs the local microbial environment 
and evokes an array of antigen-specific host responses against commensal bacterial flora. 
While it was anticipated that gnotobiotic mice would produce Thl immune responses to 
commensal flora following colonization by one or both novel bacteria, instead it was shown 
that H. Mz's-infected and dual-infected mice produced predominant serum IgGl and IL-10 
but decreased locally-derived IFN-y, suggestive of a Th2 immune response. These findings 
indicate that the nature of the gastrointestinal flora significantly influences the immunologic 
bias of the host response and the presence of Helicobacter species does not apriori predispose 
toward a Thl inflammatory response. 
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ABSTRACT 
Background and Aims: Infection with Helicobacter species has been associated with the 
development of mucosal inflammation and inflammatory bowel disease (IBD) in several 
mouse models. However, consensus regarding the role of Helicobacter as a potential 
pathogen or its utility as a model organism to study intestinal inflammation is confounded by 
the presence of a complex colonic microbiota. The aims of this study were to determine 
whether colonization of gnotobiotic mice with Helicobacter bilis provokes an antigen-
specific immune response to the resident enteric flora, and to investigate the kinetics of this 
response. Methods: Gnotobiotic C3H/HeN mice possessing a defined flora (e.g., altered 
schaedler flora consisting of 8 intestinal bacteria) were used to evaluate the host's response 
following colonization with H. bilis over a 10 week period. Immunologic parameters 
evaluated include gross cecal morphology, histopathology, mucosal immunohistochemistry, 
isotype of the antigen-specific serum antibody (ELISA), and antigen-induced Thl :Th2 
cytokine responses. Results: Results indicate that H. bilis colonized gnotobiotic mice 
demonstrate diverse antigen-specific immune responses to their resident flora in comparison 
to gnotobiotic C3H mice having a defined flora alone. The immunologic responses of the 
gnotobiotic C3H mice colonized with H. bilis developed rapidly, generally persisted over the 
10 week study and demonstrated a mixed Thl:Th2 phenotype. Although marked histologic 
lesions were not observed in H. bilis-colonized mice, alterations in mucosal B220 and CD4+ 
T cell and CD8+ T cell populations indicated that local immunity was disturbed. 
Conclusions: Gnotobiotic animals provide a useful tool for evaluation of the provocative 
potential of intestinal bacteria in the pathogenesis of intestinal inflammation. These studies 
support a potential pathogenic role for H. bilis in perturbing the normal resident microflora 
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and inducing antigen-specific immune responses against multiple resident bacterial species. 
Our model suggests that changes in the homeostatic balance of the intestinal microbiota 
(following colonization with H. bilis) and the resulting host response may initiate mucosal 
inflammation, particularly in a setting where natural tolerance to the bacterium does not 
exist. 
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Introduction 
The mammalian gastrointestinal (GI) tract harbors a complex microbial population 
which is remarkably stable throughout life and resists colonization by pathogenic bacteria.[l] 
This ecosystem is vast, both quantitatively and in terms of diversity, with the presence of at 
least 400-500 different species. [2] Most gut bacteria are commensals that coexist with the 
host in a mutualistic relationship. Several studies have demonstrated a beneficial role for the 
GI microflora in the provision of essential nutrients (e.g., vitamin K, short-chain fatty acids), 
the development of intestinal epithelium, vasculature, and lymphoid tissue, and the 
contribution to colonization resistance which protects the host from pathogenic 
infections. [3][4] 
In contrast, altered composition and functional activities of the luminal microflora 
have been linked to the pathogenesis of chronic enterocolitis, such as inflammatory bowel 
disease (IBD). A number of animal models of human IBD provide compelling evidence for 
bacterial flora driving an inflammatory process. For example, both IL-2_/~ [5] and IL-10" " [6] 
mice spontaneously develop IBD when housed under conventional conditions, but there is no 
evidence of colitis when animals are maintained under germ-free conditions. [7] Adoptive 
transfer of CD45RB1" T cells mediates less severe wasting disease in immunodeficient mice 
harboring a reduced intestinal flora [8]; furthermore, T-cell mediated gut inflammation can 
be transferred with effector T cells against enteric bacteria. [8] [9] It appears that a constant 
bacterial stimulus is needed for the induction and perpetuation of inflammation [10], and that 
resident bacteria have different capacities to induce mucosal inflammation.[11][12][13] 
These accumulated observations incriminate intestinal bacteria in the initiation and 
perpetuation of chronic intestinal inflammation, although the critical bacterial species or 
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antigen(s) remain undetermined. It is likely that select components of the normal microflora 
and the antigen-specific immune responses that they evoke are crucial for the development of 
colitis. 
Infection with Helicobacter species has been associated with the development of 
mucosal inflammation and EBD in several mouse models.[14][15][16][17][18][19] While 
some studies indicate that Helicobacter species do not induce EBD in germ-free IL-10"/" mice 
or worsen EBD in IL-lO7" mice that have been reconstituted with specific pathogen free 
(SPF) flora [7][20], others have shown that Helicobacter can be an important factor 
contributing to murine colitis in an SPF environment. [21] [22] It is clear that the consensus 
opinion regarding the role of Helicobacter as a potential pathogen or its ability to interact 
with commensal luminal bacteria and induce intestinal inflammation is confounded by the 
presence of a complex colonic microbiota. The aim of this study was to determine if 
introduction of a novel bacterial species, Helicobacter bilis, into the microflora would 
perturb the homeostatic balance (e.g., immunologically) between the host and its resident 
flora. 
Materials and Methods 
Animals 
Four-to-8 week old male and female C3H/HeN mice populated with a defined flora 
(e.g., altered Schaedler flora [ASF] comprised of 8 bacterial species) were obtained from 
Taconic Farms (Albany, NY). All mice were certified free of Helicobacter spp. by the 
vendor and re-tested on-site prior to study enrollment. Cohorts of mice were bred and 
maintained within the murine gnotobiotic facility at the College of Veterinary Medicine, 
Iowa State University (ISU). Animals were housed in Trexler plastic isolators using standard 
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gnotobiotic techniques. Mice were fed ad libitum an irradiated diet (e.g., Harlan-Teklad) and 
autoclaved water. All animal procedures were approved by the ISU Animal Care and Use 
Committee. 
Experimental Design 
Gnotobiotic C3H mice were assigned to one of two study groups: (1) defined flora 
alone receiving sham inoculations or (2) defined flora mice colonized with H. bilis. 
Representative experimental and control mice (6-12 mice per time point) were euthanized by 
CO2 asphyxiation on days 21,42, or 60 post-infection. Tissue samples were processed for 
evaluation of gross lesions, bacteriology, histopathology, immunohistochemistry, serum 
antibody levels, concentration of cytokines, and polymerase chain reaction (PCR) analysis 
for bacterial colonization. 
Infection with Helicobacter bilis 
An H. bilis isolate (ATCC strain 51630) was kindly provided by Dr Nancy Lynch 
(College of Medicine, University of Iowa). Organisms were streaked onto Columbia blood 
agar plates supplemented with 5% horse serum and grown under microaerophilic conditions 
(80 % N2,10 % H2, and 10 % CO2) and kept at 37° C. Bacteria were collected from 3-5 
plates and suspended into tryptic soy broth on the day of inoculation. Prior to inoculation, 
organisms were collected under sterile conditions and examined for their purity, morphology, 
and motility by dark phase microscopy. Samples were confirmed to be urease positive. 
Organisms were then suspended in broth to an approximate concentration of 108-109 
CFU/ml. Gnotobiotic mice were orally infected with a bacterial inoculum (0.3 ml) of H. bilis 
administered every other day for three doses. Confirmation of H. bilis infection post-
inoculum was made by PCR evaluation of feces or cecal contents and bacteriological culture. 
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Helicobacter bilis and ASF-Specific PCR 
Fecal samples or cecal contents were analyzed for the presence of Helicobacter 
spp and H. bilis as described previously. [23] [24] For generic Helicobacter PCR, 5 p.1 of 
quantitated fecal DNA was used as template while for H. bilis PCR, 10 pi of quantitated fecal 
DNA was used as template for all samples. Confirmation of ASF colonization at the 
termination of the appropriate period was performed by PCR of fecal pellet DNA from 
defined flora mice using ASF-specific primers with minor modifications made to PCR 
conditions. [25] Primers and their sequences used are summarized in Table 1. 
Size of 
Primer Position of Band ASF 
Name primer in ORF Primer Sequences Produced Member 
50-F 980-1000 CCAGGTCTTGACATCTAG 483 360 
50-R 87-1004 ACGGCTCCTTCCACATAAG 
49-F 73-90 TGCACTCACCGATAAAGAG 125 361 
49-R 178-197 GTTACCATGCGGTAACTATG 
51-F 801-818 AGGTGTGGGGGGACTGAC 320 500 
51-R 1103-1121 CTAGAGTGCTCTTGCGTAG 
52-F 792-811 GTGTCGGGGAGGAATTCCC 461 356 
52-R 1232-1253 GGTTTTTGTGCTTTGCTTAACG 
53-F 48-65 GAAGCACTTTTTTAGAAC 147 502 
53-R 175-195 GTACCATGCGGTACCGGGGTC 
54-F 194-212 GTTTTAAAAAGAAAACTCC 442 492 
54-R 617-636 CCTCCGACACTCCAGCCCGG 
55-F 145-166 ATGCCGGATGAGTTATATAAG 855 457 
55-R 980-1000 CATTATCTCTAACGCCTTCTG 
56-F 148-168 CTAATACCGCATAAAACAGGG 685 519 
56-R 815-833 GTGCCGCTTACTGTGTATC 
Table 1. Primer sequences for identification of ASF bacteria. Primer sequences for 
identification of ASF361 and ASF492 are different than previously published sequences.25 
Modifications to primer sequences for detection of ASF361 and ASF492 were based on 
optimized PCR conditions and product detection using a multiplex format as compared to 
bacterial DNA positive control. ASF 356 = Clostridium cluster XIV; ASF 360 = 
Lactobacillus acidophilus; ASF 361 = Lactobacillus animalis; ASF 457 — Flexistipes 
phylum; ASF 492 = Eubacterium plexicaudatum; ASF 500 = Low G + C-content spp.; ASF 
502 = Clostridium cluster XIV; ASF 519 = Bacteroides distasonis. 
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Preparation of H. bilis and Bacterial Antigens 
Helicobacter bilis organisms were cultivated in Columbia broth, recovered, and 
the bacteria collected by centrifugation. The cells were washed with sterile PBS, the cell 
pellet was frozen, cells were lyophilized, and then stored at -20° C until used. 
Each member of the schaedler flora (ASF 360, ASF 361, ASF 356, ASF 457, ASF 
492, ASF 500, ASF 502, and ASF 519) was grown in anaerobically prepared medium and 
cultured at 37°C for five to seven days. Cells were grown in either reinforced Clostridium 
medium (RCM) supplemented with 5 % calf serum (ASF 360, ASF 361, ASF 356, ASF 502, 
and ASF 519) or schaedler broth supplemented with 5 % sheep serum (ASF 457, ASF 492, 
and ASF 500). Because many of these organisms are extremely oxygen sensitive (EOS), all 
inoculations were performed in a Coy anaerobic chamber. Culture flasks were sealed in 
anaerobic jars and then placed in an incubator. As above, the cells were harvested from broth 
by centrifugation, washed in PBS, and lyophilized. 
Bacterial antigens (e.g., H. bilis and all eight ASF strains) used for ELISA or for 
stimulation of lymphocyte cultures were prepared from the lyophilized cells. Briefly, cells 
were weighed and resuspended in buffer or tissue culture medium to a final concentration of 
2 mg/mL (dry weight to volume). The cell suspension was then placed on ice and sonicated 
for 5 minutes to prepare whole cell sonicates (WCS). Sonication was performed using 30 
second pulses to prevent the suspension from overheating (i.e., denaturing of the proteins). 
Cell disruption was monitored microscopically. Protein content was determined by BCA 
(Pierce Laboratories). For the preparation of antigen for in vitro stimulation of lymphocytes, 
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the WCS were sterilized by UV light. Additionally, sterility was confirmed by 
bacteriological methods (e.g., aerobic and anaerobic blood agar cultures). These methods 
were used to prepare all antigens used for these studies. In order to ensure that all studies 
were performed with the same lot of antigens, each of the bacterial species to be used was 
grown during the first six months of the project to provide sufficient antigenic mass to 
complete these experiments. 
Evaluation of Macroscopic Cecal Lesions 
Macroscopic cecal lesions were scored using previous published criteria. [26] In 
brief, ceca were evaluated macroscopically for atrophy, edema, and increased mucus in the 
ingesta, given a gross lesion score (0-3: 0 = normal, 3 = severe cecal lesion), and placed in 
10% neutral buffered formalin for histopathologic evaluation. 
Histopathologic Evaluation of Murine Tissues 
Sections of cecum and proximal colon were routinely processed, embedded in 
paraffin, and sectioned at 5pm for microscopic examination. Cecal and intestinal mucosa 
were stained with hematoxylin and eosin (H&E) for assessment of inflammation. Tissue 
sections were coded to blind the pathologist (JH) to the infection status of the animal. The 
cecum and proximal colon from each mouse were scored on severity of mucosal epithelial 
damage, architectural/glandular alterations, and magnitude/character of lamina propria 
cellular infiltrate (Table 2). 
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Table 2. Scoring System for Histopathological Evaluation of 
Gastrointestinal Inflammation 
Parameters Scoring Criteria 
Mucosal height 
LP immune cells 
Ratio of crypt depth to width 
Rising score from 1 -5 (mild—severe hyperplasia) 
Lymphocytes/plasma cells are the expected population 
Mixed inflammation = increased neutrophils 
Erosions 
Inflammatory score 
Edema score 
Rising score from 1 -5 (0 = no erosions; 5 = ulceration 
Denotes quantity of cellular infiltrates in the LP 
Rising score from 1-5 (normal severe inflammation with necrosis 
Rising score from 1-5(1 - mild edema; 5 = severe edema wi'tfi-
architectural distortion) 
Other Submucosal lymphoid hyperplasia (present of absent) 
Table 2. Scoring system used for the histopathological evaluation of gastrointestinal 
inflammation. LP = lamina propria. 
Analysis of Antigen-Specific Serum Antibodies 
Serum antibody levels in mice were determined by ELISA as previously 
described. [27] Briefly, 96-well plates were coated with sonicated whole cell lysates of each 
of the eight anaerobic bacteria comprising the ASF and H. bilis. Diluted serum (1:200) was 
added to each well and incubated at 4° C overnight. Then, alkaline phosphatase conjugated 
goat anti-mouse IgGl or IgG2a was added and incubated for 1 hour at room temperature. 
Wells were developed using p-nitrophenyl phosphate at room temperature. Color changes 
were measured using an ELISA plate reader at 405 nm. 
Immunohistochemical Analysis 
Cecal tissue sections were placed in an enriched cryopreservative media (O.C.T.), 
snap frozen on dry ice, stored at -80° C, and later warmed to -20° C, sectioned at 6|im, and 
stained for identification of mucosal CD4+ and CD8+ T cells and B220 B+ cells. Endogenous 
75 
peroxidase was inhibited by incubating tissue in buffer containing 0.3% H2O2. Antibodies 
used for section staining included: biotinylated rat anti-mouse CD4 (clone GK 1.5; l|ig/ml, 
Becton Dickenson); biotinylated rat anti-mouse CD8a (clone 53-6.7; 1 p.g/ml, Southern 
Biotechnology); and biotinylated rat anti-mouse CD45R (B220) (clone RA3-6B2; 1 fig/ml, 
PharMingen). All monoclonal antibodies were diluted in 1% (vol/vol) PCS in PBS. 
Streptavidin-HRP (1:2000) was added and the tissues incubated for 30 minutes at room 
temperature. A diaminobenzidine chromogen was used to visualize stained cells and sections 
were lightly counterstained with hematoxylin. Mucosal cell populations were enumerated 
using an ocular grid. Cells were quantified by a single investigator (ZL) evaluating 5-10 
randomly selected and optimally-oriented microscopic fields (160x or 400x) per section. 
Cytokine Analysis by Multiplexed Flow Cytometric Assay 
Lymphocytes isolated from the spleen and mesenteric lymph nodes were 
incubated at 2.5 x 106 cells per ml with or without whole cell lysates of the ASF organisms 
and H. bilis for 72 hours. Cell cultures were treated with concanavalin A to evaluate the 
overall nature of the T cell response. Cell-free supernatants were harvested and analyzed for 
their concentration of Thl (TNF-a, IFN-y, IL-2, IL-12) and Th2 (IL-4, IL-10) cytokines 
using a multiplexed flow cytometric assay (The FlowMetric™ System, Luminex, Austin, 
TX). Cytokine concentrations were measured using a murine cytokine detection kit (Mouse 
Cytokine LINCOplex Kit, Linco Research, St. Charles, MO) specifically designed for use 
with the Luminex systems. 
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Statistical Methods 
For immunohistochemical analysis, mucosal immune cell populations were expressed 
as mean cells per microscopic field + standard error of the mean (SEM). Cells counts in the 
2 murine groups (control versus H. 6//zs-infected) were then compared using a non-
parametric analysis. Serum antibody data were evaluated in two ways. First, the ratio of 
absorbance recorded in H. 6z7z's-infected mice to absorbance recorded in non-infected 
controls was determined at 3-, 6-, and 10-weeks PI. These antibody ratios were then 
expressed as the mean ratio OD (absorbance) + standard deviation. Secondly, non-
parametric analysis was performed on the means and SEM of the pooled optical density 
(absorbance) for all 8 ASF antigens at 3-, 6-, and 10 weeks PI. The IgG isotype responses to 
H. bilis antigen were assessed using identical analyses as per the pooled ASF antibody 
responses. 
For analysis of cytokine concentrations, the study design had 4 factors: organ (2 
levels), cytokine (5 levels), organism (8 levels) and time (3 and 4 levels). Comparisons 
among levels of factors (e.g., spleen versus lymph node) were performed by testing the 
difference in proportions of median responses (e.g., determined as the ratio of antigen-
specific cytokine concentration to background [no stimulation] concentration) that were at 
least 4 times background level. The normal approximation to the binomial distribution was 
assessed as valid and was used as the inferential procedure.[28] These were planned 
comparisons (rather than post-hoc), so that it was not necessary to adjust the P-values to 
control for type I error inflation.[29] A f-value of < 0.05 was considered statistically 
significant for all inferences. 
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Results 
Colonization with H. bilis and ASF Bacteria 
Mice inoculated with H. bilis became positive by fecal PCR 12-14 days post­
infection and remained so for the 10 week study period (Figure 1). Both Helicobacter genus 
and H. Mzs-specific primers consistently detected colonization. In some instances, culture of 
cecal contents at necropsy was also performed to confirm colonization with Helicobacter 
spp. Uninfected control animals remained Helicobacter fecal PCR and bacteriologically 
negative. Specific PCR products were reliably obtained by amplification of feces or cecal 
contents obtained at necropsy from defined flora mice using the ASF-specific primers in a 
multiplex format. Consistent with recent observations [25], detection of ASF member 360 
from cecal contents of different mice at different time points was variable. 
Figure 1. Photograph of an agarose gel depicting PCR analysis of murine fecal samples 
for the presence of H. bilis, C3H/HeNTac mice bearing a defined bacterial flora were 
colonized six weeks prior to sample collection with H. bilis. Fecal samples were 
collected and extracted using the QIAamp DNA Stool kit (Qiagen) to recover bacterial 
DNA. Using specific PCR primers for H. bilis, fecal samples from 11 separate mice 
were assayed for the presence of H. bilis. Sample 1, DNA from pure culture of H. bilis; 
Samples 2-10, fecal samples from gnotobiotic mice orally inoculated with H. bilis six 
weeks earlier; Samples 11-12, fecal samples from control gnotobiotic mice sham 
inoculated with sterile culture media. Outside lanes contain DNA size markers. 
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Clinical, Gross, and Histopathologic Findings Observed in H.6z7»-lnfected Defined 
Flora Mice 
Over the 10 weeks of the study, wasting disease and overt diarrhea were not observed 
in H. bilis infected mice. Similarly, there was no significant weight change in H.bilis 
infected mice as compared to non-infected controls (data not shown). Significant differences 
in cecal morphology subsequent to H. bilis colonization were not observed at necropsy; 
however, infected ceca were uniformly smaller with regional mesenteric lymphadenopathy 
frequently present in 6-and 10-week infected mice as compared to non-infected controls. 
Microscopic changes of mild inflammation were observed in cecal tissue recovered 
from 3- and 6-week H. bilis infected mice. Histopathologic findings included increased 
cellular infiltrates, diffuse epithelial erosions, and submucosal edema. The cellular infiltrate 
in these specimens was confined to the lamina propria and consisted primarily of 
lymphocytes and plasma cells. While an increase in inflammation (e.g., increased mucosal 
cellularity, mucosal hyperplasia, submucosal edema, lymphoid hyperplasia [Figure 2]) and 
histology scores was noted for cecal tissues from 10-week infected mice, these changes were 
not significant. 
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Figure 2. Histological changes in the cecal mucosa of defined flora mice after infection with 
H. bilis. (A) Controls - no infection; (B) Mice infected with H. bilis for 6 weeks - mild 
typhlocolitis is evident and is characterized by the presence of submucosal edema, mild 
infiltration of the lamina propria (LP) with mononuclear cells and mild crypt hyperplasia; (C) 
Mice infected with H. bilis for 6 weeks - moderate typhlocolits as evidenced by marked 
mononuclear and neutrophilic infiltrates in the LP accompanied by moderate crypt 
hyperplasia. All images at 100X. 
Antigen-Specific IgGl/IgG2a Antibody Responses Subsequent to H.bilis Colonization 
Mis-infected gnotobiotic mice demonstrated diverse antigen-specific immune 
responses to their resident flora in comparison to non-infected mice (Figure 3A). Antibody 
responses developed quickly, persisted over the 10-week study, and they demonstrated a 
mixed Thl:Th2 phenotype. At all time points evaluated, pooled IgGl and IgG2a responses 
to ASF antigens were significantly (P<0.05) increased in infected mice as compared to non-
infected controls (Figure 3B). Furthermore, the IgGl response to pooled ASF antigens at 6-
weeks PI was significantly (P<0.05) increased as compared to the IgGl levels seen in 10-
week infected mice. It is noteworthy that IgG responses to several ASF members including 
ASF 457 (increased IgG2a at 10-weeks PI), ASF 500 (increased IgG2a at 10-weeks PI), ASF 
502 (increased IgGl at 3-weeks PI), and ASF 519 (increased IgG2a at 10-weeks PI) were 
significantly (P<0.05) increased as compared to the antibody response to other ASF 
members. The IgGl and IgG2a responses to H.bilis were significantly (P<0.05) increased at 
80 
6-weeks PI when compared to antibody responses observed in mice 3- and 10-week PL 
Serum collected from control DF mice did not demonstrate any antibody response to H. bilis 
antigens (Figure 4) at any time point (data not shown). 
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Figure 3A. Serum immunoglobulin responses from H. Mzs-infected defined flora (DF) mice 
and non-infected DF mice. Immunoglobulin isotypes (IgGl and IgG2a) to bacterial antigens 
of the altered schaedler flora (ASF) at 3-, 6,- and 10-weeks post-#, bilis infection are shown. 
H. bilis-infected DF mice produce a broad immunoglobulin response to numerous ASF 
antigens which generally peaks at 3 to 6 weeks post-infection. Numbers reflect means and 
standard deviations of the ratio of optical density (e.g., ratio OD calculated as the ratio 
absorbance in H. bilis-infected mice to absorbance in non-infected mice). Each mean value 
comprises triplicate wells of individual mouse serum from 4-8 mice per group averaged over 
3 independent experiments. ASF 356 = Clostridium cluster XTV; ASF 360 = Lactobacillus 
acidophilus; ASF 361 = Lactobacillus animalis; ASF 457 = Flexistipes phylum; ASF 492 = 
Eubacterium plexicaudatum; ASF 500 = Low G + C-content spp.; ASF 502 = Clostridium 
cluster XIV; ASF 519 = Bacteroides distasonis. 
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Figure 3B. Pooled serum immunoglobulin levels from H. bilis-infected defined flora (DF) 
mice and non-infected (control) DF mice. Serum immunoglobulin responses (IgGl and 
IgG2a) to bacterial antigens of the altered schaedler flora (ASF) at 3-, 6- and 10-weeks post­
ai. bilis infection were determined by ELISA as described in materials and methods. 
Numbers reflect the means and SEM of the pooled optical density (absorbance) for all 8 ASF 
antigens averaged over 3 independent experiments. 
* P<0.05 for H. bilis-infected mice versus control (non-infected) mice. 
f P<0.05 for H. bilis-infected mice at 6 weeks versus H. Mis-infected mice at 10 weeks. 
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Figure 4. Pooled serum IgG isotype responses from H. Mis-infected defined flora mice. 
Absorbance determined at 3-, 6-, and 10-weeks post-infection (PI) as described in materials 
and methods. Numbers reflect the means and SEM of the pooled optical density 
(absorbance) for H. bilis IgGl and IgG2a averaged over 3 independent experiments. 
* P<0.05 for IgGl at 6 weeks-PI versus 3- and 10-weeks PI. 
f P<0.05 for IgG2a at 6 weeks-PI versus 3- and 10-weeks PL 
Alterations in Mucosal B and T Lymphocyte Populations in 11. Mzs-Infected Mice 
Colonization of defined flora C3H mice with H. bilis was associated with altered 
mucosal populations of B and T lymphocytes. As compared to non-infected control mice, 
ocular morphometry revealed that CD4+ T cells were the most numerous mucosal immune 
cell within the lamina propria in infected mice followed by lesser numbers of CD8a+ T cells 
and B220 cells. For each cell type evaluated, there appeared to be a similar trend with mean 
cell numbers peaking at 3 weeks then declining towards the number of cells detected at time 
0 (baseline) by week 10 (Figure 5). 
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Figure 5. Alterations in mucosal T and B lymphocyte populations from H. bilis-infected 
defined flora (DF) mice (red bars) and non-infected DF mice (green bars). Mucosal 
cellularity of CD4+ T cells, CD8a+ T cells and B220 cells is increased at 3-, 6-, and 10-weeks 
post-infection in H. bilis-infected mice compared with non-infected DF mice. Two columns 
of data are shown. Left column - mean cells per microscopic field and standard deviations 
derived from pooled tissues of 6-8 mice per group. Right column - representative 
immunohistochemical staining of cecal tissues using monoclonal antibodies for CD4 (top), 
CD8a (middle), and B220 (bottom). 
*P<0.05 for H. bilis-infected versus non-infected for each cell type. 
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Antigen-Specific Cytokine Responses Obtained from Lymphocyte Cultures 
Supernatants derived from antigen stimulated lymphocytes derived from H. bilis-
infected defined flora mice showed elevated levels (pg/ml) of IFN-y, TNF-a, IL-6, IL-10, and 
IL-12 but marginally detectable levels of IL-2 and IL-4. Therefore, subsequent analysis of 
IL-2 and IL-4 cytokines was not performed. Overall, more numerous and robust (at least 
four-fold) responses to ASF members were observed from antigen-stimulated splenic 
lymphocyte cultures (Table 3). In contrast, mesenteric lymph node supernatants produced 
lesser quantities of each cytokine at all time points with the exception of IL-6. Evaluation of 
these immunologically compartmentalized responses demonstrated that the overall splenic 
response (e.g., concentration ratios for IFN-y, TNF-a, IL-6, and IL-10 at 3-, 6-, and 10-weeks 
post-infection and for IL-12 at 3- and 6-weeks post-infection) significantly (P<0.05) 
exceeded the cytokine response derived from mesenteric lymph node cultures (Table 4). 
Significantly (P<0.05) greater overall cytokine responses were induced by stimulation with 
ASF members 360, 500, 502, and 519 in comparison to responses of stimulated lymphocytes 
derived from the mesenteric lymph node. A comparison of individual cytokine responses 
between immune compartments showed that the concentration derived from splenic 
lymphocyte cultures for each cytokine was significantly (P<0.05) greater than the ratio 
produced by the same cytokine derived from mesenteric lymph node cultures (e.g., splenic 
IFN- y > mesenteric lymph node IFN-y, etc.). 
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Table 3. Increased concentrations of cytokines in mesenteric lymph node (MLN) and splenic (SPL) 
supernatants derived from altered schaedler flora (ASF) bacteria stimulated lymphocytes in H. bilis-
infected defined flora (DF) mice and non-infected DF mice. Lymphocytes were cultured for 72 
hours, then supernatants were harvested and surveyed via multiplexed flow cytometric assay. 
*Reactive ASF bacteria are denoted by an X, and comprise those bacterial members which evoked at 
least a four-fold increase in median cytokine concentration (determined as the ratio of antigen-
specific cytokine concentration to background [no stimulation] concentration) subsequent to 
stimulation. Note the apparent compartmentalized responses between MLN and SPL cultures. ASF 
356 = Clostridium cluster XIV; ASF 360 = Lactobacillus acidophilus; ASF 361 = Lactobacillus 
animalis; ASF 457 = Flexistipes phylum; ASF 492 = Eubacterium plexicaudatum; ASF 500 = Low 
G+ C-content spp.; ASF 502 = Clostridium cluster XIV; ASF 519 = Bacteroides distasonis. 
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Variable Analysis /•-value 
Total cytokines3 SPL versus MLN 0.00001 
IFN-y SPL versus MLN 0.0389 
TNF-a SPL versus MLN 0.0199 
IL-6 SPL versus MLN 0.0455 
IL-10 SPL versus MLN 0.00001 
IL-12" SPL versus MLN 0.0014 
ASF 356 SPL versus MLN 0.5475 
ASF 360 SPL versus MLN 0.0364 
ASF 361 SPL versus MLN 0.6313 
ASF 457 SPL versus MLN 0.6756 
ASF 492 SPL versus MLN 0.0970 
ASF 500 SPL versus MLN 0.0013 
ASF 502 SPL versus MLN 0.0086 
ASF 519 SPL versus MLN 0.0224 
Table 4. Summary data of cytokine analysis in gnotobiotic mice. See methods section for 
explanation of statistical analyses performed. * Analyses reflect direct comparison of median 
cytokine concentrations derived from splenic (SPL) and mesenteric lymph node (MLN) 
cultures. For all comparisons, a f-value < 0.05 is considered statistically significant. ASF 
356 = Clostridium cluster XIV; ASF 360 = Lactobacillus acidophilus; ASF 361 = 
Lactobacillus animalis\ ASF 457 = Flexistipes phylum; ASF 492 = Eubacterium 
plexicaudatum; ASF 500 = Low G+ C-content spp.; ASF 502 = Clostridium cluster XIV; 
ASF 519 = Bacteroides distasonis. 
a Comparison of all cytokines (e.g., IFN-y, TNF-a, IL-6, IL-10, and IL-12) across all time 
points (e.g., time 0, 3-, 6-, and 10-weeks post-#, bilis infection for all cytokines but IL-12 
which was evaluated only at 0, 3-, and 6-weeks post-#, bilis infection). 
b Only supernatant samples at time 0, 3-, and 6-weeks post-#, bilis infection were available 
for analysis. 
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Discussion 
Determining the relative contributions of host responses to enteric bacteria which 
modulate intestinal inflammation is problematic due to the presence of a complex microbiota. 
To assess which subsets of resident bacteria are most responsible for induction of 
experimental gastrointestinal inflammation, gnotobiotic studies employing a defined flora 
host colonized with a single (e.g., monoassociated) bacterium or combination of a limited 
number of bacteria species have been performed. Reconstitution studies in gnotobiotic HLA-
B27 transgenic (TG) rats containing six different obligate and facultative intestinal anaerobic 
bacteria, including Bacteroides vulgatus, develop much more active colitis and gastritis than 
littermates colonized with the same selected bacteria without B. vulgatus. [ 11] Furthermore, 
HLA-B27 TG rats colonized with SPF bacteria had more inflammation than gnotobiotic rats 
colonized with the defined flora including B. vulgatus. In subsequent monoassociation 
studies, it has also been shown that B. vulgatus but not E. coli induced colitis of equal 
severity to that observed in gnotobiotic TG rats.[30] Helicobacter species may or may not be 
associated with gastrointestinal inflammation in different animal models depending upon the 
composition of the resident flora and host susceptibility. [ 17] [22] [31 ][32] [33] [34][3 5] These 
accumulated results suggest that a subset of luminal bacteria (especially anaerobes) have 
differing abilities to contribute to the onset of colitis, that introduction of a novel bacterium 
perturbs the local microbial ecology thereby provoking host immune responses, and that this 
ecological and/or immunological perturbation provides the constant antigenic stimulus for 
immune-mediated colonic inflammation. 
Other studies performed using a variety of experimental models have shown that the 
resident microflora plays an important role in the pathogenesis of 
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IBD.[5][6][7][36][37][38][39] In most of these models, Thl immune responses are directed 
toward commensal intestinal bacteria and contribute to gut inflammation. Salient examples 
of these phenomena include colitis which may be caused by the transfer of bacterial antigen-
specific CD4+ T cells from spontaneously colitic C3H/HeJ Bir mice [9]; the observation that 
monoassociated IL-10" " mice develop antigen-specific immune responses to colitis-
producing bacteria (e.g., E. coli, Enterococcus faecalis) but not to bacteria incapable of 
producing disease [40]; the finding that CD4+ T cells derived from C3H/HeJBir mice 
demonstrate strong antibody (e.g., IgG2a) reactivity to certain antigens derived from the 
resident enteric flora (e.g., Enterococcus spp. and Enterobacteriaceae) but not to epithelial 
cells or to food antigens [41]; and observations by Onderdonk et al that show that high 
concentrations of E. coli and Enterococcus species are associated with severe colitis in HLA-
B27 TG rats. [42] While it is clear that luminal bacteria have important but complex roles in 
initiating and sustaining intestinal inflammation, the contribution of antigen-specific host 
responses directed against resident flora in this process has not been critically evaluated. 
We initially investigated host immune reactivity to the resident microflora in 
conventionalized C3H mice infected with the spirochete, Brachyspira 
hyodysenteriae. [26] [43] [44] Previous experiments have indicated that infected mice develop 
a polarized Thl response characterized by prominent IgG2a production, increased IFN-y 
secretion, and severe typhlocolitis (MJ Wannemuehler, unpublished data). The resident 
microflora is a important cofactor for disease development in this model as the use of 
antibiotic therapy to selectively deplete members of the microflora (e.g., gram-negative 
anaerobes) abolishes the ability of the spirochete to induce colitis. [45] In subsequent studies, 
we have confirmed the presence of Helicobacter spp. in inflamed ceca suggesting that these 
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bacteria potentially contribute to intestinal inflammation in infected mice. [46] To further 
explore the pathogenesis of microbial-induced colitis, we infected gnotobiotic C3H mice 
(harboring an ASF flora) with H. bilis and evaluated antigen-specific immune responses to 
the resident flora. We found that the introduction of H. bilis into defined flora mice evoked 
diverse host responses to commensal ASF members and that this perturbation may "trigger" 
the development of colitis. 
Helicobacter spp. have been incriminated as provocateurs of microbial-induced 
colitis in a number of animal models. In separate experiments, H. hepaticus induced chronic 
colitis in SPF-reared IL-10"7" mice [21] and caused significant mucosal inflammation in the 
cecum and colon of TCR-aP mutant mice. [15] Burich et al observed that both H. bilis and H. 
hepaticus may cause histologic lesions of EBD of varying severity in genetically susceptible 
hosts. [22] The monoassociation of SCID mice with H. muridarum provokes the 
development of IBD; however, these mice did not develop wasting disease or colitis. [19] 
Still other models suggest a less pathogenic role for Helicobacter spp. and have shown that 
Helicobacter does not induce IBD in germ-free IL-10"7" mice [20] or potentiate IBD in 
germfree IL-10"7" mice reconstituted with a SPF flora. [7] Also, H. hepaticus infection delays 
the development of EBD in mdrla"7" mice. [47] We and others [22] suggest that the 
contrasting observations from some studies are due to variability in genetic susceptibility to 
IBD and to different compositions of intestinal flora in these animal models. The use of an 
immunocompetent gnotobiotic mouse which harbors a defined flora with a limited number of 
bacterial species (which are stable from mouse to mouse), such as the model used in the 
present study, represents a unique opportunity for evaluating the specificity of the resident 
flora in the initiation of intestinal inflammation.[25] Additionally, evaluation of host 
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responses in mice having a functionally normal immune system is more realistic to the 
human condition, where IBD predominantly effects immunologically-competent patients. 
Defined flora mice infected with H. bilis developed only mild, histologically-evident 
typhlocolits after chronic colonization. Significant wasting disease with watery diarrhea was 
not observed; however, many mice were noted to have pasty, mucoid feces at necropsy. 
Gross lesions of cecal involution and mesenteric lymphadenopathy were common in 6- and 
10-week infected mice in comparison to non-infected gnotobiotic mice. Histologic lesions of 
mild typhlocolitis were characterized by increased mucosal infiltrates, submucosal edema, 
and increased inflammatory scores which worsened over time. Additionally, both the 
quantity and character of the lamina proprial infiltrate changed (e.g., from a mononuclear cell 
infiltrate to that containing increased neurtrophils) in tissues evaluated from 10-week H. 
Mz's-infected mice. Our findings of mild colitis in mice colonized with H. bilis have been 
reported by others using Raglv" mice, that lack both B and T lymphocytes.[22] 
An unexpected finding in this study was the balanced Thl :Th2 profile of host 
immune responses following colonization with H. bilis. In most instances, these responses 
were persistant with regards to cytokine production and exhibited distinct patterns of 
compartmentalization between the spleen and mesenteric lymph node. Gnotobiotic mice 
infected with H. bilis developed a dominant serum IgG2a antibody response at 6 weeks PI 
(e.g., Thl profile) as previously observed in other animal models infected with Helicobacter 
spp.[21][48][49][50] Antibody responses to ASF members for both immunoglobulin 
isotypes followed a similar pattern of peaking at 6 weeks post-infection. The observed IgGl 
(e.g., Th2-like) response to select ASF bacteria following H. bilis colonization was 
unexpected. Our hypothesis for this observation is that this Th2 immune bias develops 
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following the introduction of H. bilis into the gut because this alters or perturbs the local 
microbial ecology, thereby influencing the immunological response of the host to non­
pathogenic luminal bacteria. 
We observed disturbances in local immunity (e.g., alterations in mucosal B and T 
lymphocyte populations) of H.bilis-infected mice that broadly correlated with peak antibody 
responses. Immunohistochemical studies performed on cecal tissues of H. bilis-infected 
mice showed increases in CD4+ T cells, CD8+ T cells, and B220+ cells which then decreased 
to baseline values by week 10 of infection. The phenotype (e.g., helper or regulatory T cell) 
and antigen specificity of the infiltrating CD4+ T cells was not determined; however, it is 
tempting to speculate that the increase was in response to conventional antigens of the 
bacterial flora as reported by others.[9][51] 
Up-regulation of Thl cytokines like IFN- y and TNF-a has been noted in other 
bacterial models of IBD [52] and has been reported to characterize Helicobacter-mâuced 
disease. [21] [22] [49] Thus, it was not surprising to observe increases in these cytokines along 
with IL-6 in lymphocyte supernatants following antigenic stimulation. It was noteworthy 
that increased production of IL-12 was observed in lymphocyte cultures from both the lymph 
nodes and spleens recovered from mice colonized with H. bilis. The production of IL-12 
from macrophages or dendritic cells may occur in response to diverse stimuli including live 
bacteria, bacterial products such as LPS and lipotechoic acid, and/or prokaryotic 
DNA.[53][54][55][56] The results of this study suggest that resident luminal bacterial 
products may also stimulate IL-12 production. IL-12 induced by stimulation with microbial 
products has been associated with the development of autoimmune disease [39] and loss of 
tolerance to resident luminal bacteria in experimental colitis.[57] It is also possible that 
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increased IL-12 production caused excess production of pro-inflammatory IFN-y, thereby, 
altering gut epithelial barrier integrity. While this contention would be histologically 
supported by the presence of overt inflammation, one explanation for the lack of mucosal 
inflammation in this model is that lesion severity was attenuated by the increased production 
of IL-10. Animal studies have shown that IL-10 may modulate inflammatory responses in 
IBD, presumably through regulatory T cell activity.[57][58] In contrast, Maggio-Price et al 
have shown that severe IBD may occur in conjunction with increased colonic IL-10 in 
mdrlai1' mice infected with H. hepaticus, and that delayed development of IBD is not 
necessarily accompanied by increased production of IL-10 in these same mice. [47] Future 
studies will more specifically address the role of IL-10 in modulation of typhlocolitis in H. 
Mzs-infected gnotobiotic mice. 
The up-regulated antigen-specific cytokine responses observed from splenic cultures 
demonstrate that compartmentalized host responses to the resident bacteria occur subsequent 
to H. bilis colonization. Furthermore, these data suggest that different members or 
subpopulations of resident bacteria have the potential to initiate host immune responses and 
contribute to the onset of colitis. Mechanisms by which H. bilis colonization evokes host 
immune responses in these mice are not fully known. As semi-quantitative PCR confirmed 
the presence of all ASF bacteria on necropsy, alterations in commensal members following 
H. bilis colonization seem unlikely. It is possible that quantitative differences in bacterial 
numbers or their location within the gut (e.g., luminal versus adherent - not measured in this 
study) following H. bilis infection might have influenced the intensity of immune responses 
to the individual ASF members. [7] Additionally, Helicobacter spp. may initiate the 
development of intestinal inflammation through diverse mechanisms including the 
93 
elaboration of specific toxins (e.g., cytolethal distending toxins) [59], IFN-y -mediated 
compromise of intestinal epithelial barrier function [47] [60], the recruitment of commensal-
specific CD4+ T cells to the colonic lamina propria [9], LPS-mediated activation of toll-like 
receptors found on dendritic cells and macrophages which trigger the innate immune system 
[22], and/or altered epithelial cell gene expression. Whether some or all of these mechanisms 
are responsible for the initiation of intestinal inflammation in immunocompetent C3H mice 
bearing a defined flora mice following colonization with H. bilis remains to be determined. 
These results indicate (suggest) that perturbation of the microbial ecology, following 
the introduction of a novel bacterial species such as H. bilis, may predispose or set the stage 
for the development of colitis in gnotobiotic mice. It would appear that normal luminal 
bacteria play an important role in the initiation of host immune responses, that these 
responses are of mixed Thl :Th2 phenotype, that these responses are compartmentalized in 
their magnitude, and that further studies are warranted. Lastly, some commensal bacteria 
may exert a more dominant role than others in the induction of colitis, particularly in a 
setting where natural tolerance to the introduced bacterium does not exist. [22] 
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CHAPTER 4. GENERAL CONCLUSIONS 
To better understand how bacteria "trigger" intestinal inflammation in a 
susceptible host, we have developed a novel mouse model of bacterial-induced colitis. 
In a series of subsequent experiments, we used this model to investigate host-microbial 
interactions contributing to the development of typhlocolitis in gnotobiotic mice. This model 
would appear to have several advantages over other models of intestinal inflammation 
including: (a) the initiating etiologic agent (B. hyodysenteriae) is known; (b) mice having a 
defined flora with a limited number of bacterial species (which are consistent from mouse to 
mouse) is needed to develop gut inflammation; (c) this model provides reproducible 
typhlocolitis quickly and consistently allowing chronological studies of both acute and 
chronic inflammation to be performed; and (d) immunocompetent mice are used to assess the 
host's immune response following onset of colitis. 
While immune responses of the gnotobiotic mice of in our preliminary studies 
were of mixed Thl/Th2 phenotype, the original pilot data (e.g., experiment 1 in the dual-
infection study [paper 2]) did not establish whether these responses were persistent over time 
or the nature of the microbial populations associated with them. The H. bilis temporal 
studies (paper 1) did address the kinetics of the host immune responses to the ASF bacteria 
over time in a systematic fashion. These additional experiments revealed that host responses 
persist ad a mixed Thl :Th2 expression over the 10-week study period, that these responses 
are compartmentalized (e.g., spleen versus mesenteric lymph node) in their magnitude, and 
that some commensal bacteria may exert a more dominant role than others in the induction of 
host responses modulating the development of colitis. These accumulated data clearly 
indicate that future studies evaluating host responses following introduction of a novel 
101 
bacterium in defined flora mice are warranted. In particular, we would like to more critically 
evaluate sub-populations of the ASF and the relative contributions they make with regards to 
generation of host immune responses. 
FUTURE STUDIES OVER THE NEXT 2 YEARS 
Specific Aim. Evaluate the characteristics of the resident flora that are critical in eliciting 
immune responses in experimental colitis. 
Rationale: These proposed experiments will examine host-microbial interactions which test 
the hypothesis that specific resident bacteria are important in triggering immune 
responses. Based on our preliminary data, we have noted that select ASF bacteria in 
gnotobiotic mice tend to be more or less immunogenic as previously measured. However, 
which critical "mix" of flora is most important at evoking immune responsiveness has not 
been demonstrated. Selective bacterial reconstitution studies in germfree mice will be 
performed to evaluate the resultant immune response. Characterization of the identity and 
location of ASF bacteria contributing to antigen-specific immunity will be performed by 
fluorescent in situ hybridization (FISH). 
Experimental Design 
Derivation of germ free mouse groups. 
Three to six week old germfree (GF) C3H mice will be obtained from Taconic 
Farms. Foundation stock for this strain is cesarean-derived with expansion stock maintained 
under germfree conditions. All mice will be certified free of bacterial species, including 
Helicobacter spp., by the vendor and retested on site before each experiment. Animals will 
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be strictly housed in a germfree environment in gnotobiotic isolators while at our facility. 
The GF mice will be assigned to one of 4 treatment groups based on H. bilis and B. 
hyodysenteriae infection status: Group 1 (control) - entirely GF with no bacterial infection; 
Group 2 - infected with B. hyodysenteriae alone; Group 3 - infected with H. bilis alone; 
Group 4 - infected with H. bilis and B. hyodysenteriae. Following bacterial reconstitution 
experiments (described below), representative control and experimental mice will be 
euthanized on day 75 PI and samples will be taken for gross cecal morphology, 
histopathology, immunohistochemistry, bacteriology, serum antibody levels, B cell 
ELISPOT, and levels of cytokines. 
Bacterial reconstitution studies. 
The 8 ASF species will be equally divided into 2 types of organisms based on 
their ability to evoke antigen-specific immune responses as measured in our preliminary 
studies. Type A organisms will consist of those defined flora bacteria which were generally 
observed to be more immunogenic - ASF members 356, 361,457, and 492. Type B 
organisms will consist of those defined flora bacteria which were generally observed to be 
less immunogenic - ASF members 360,500,502 and 519. Earlier work has established the 
need to introduce a Lactobacillus spp. (e.g., ASF 360 or 361) first, to facilitate colonization 
by other more oxygen-sensitive ASF members. Presumably, these Lactobacilli lower the 
luminal redox potential favoring growth conditions for EOS bacterial species. The 4 GF 
murine groups will then be colonized by both Type A and Type B defined bacterial species in 
separate experiments. We will next compare the effects of Type A (more immunogenic) 
bacteria and Type B (less immunogenic) bacteria on induction of Thl and Th2 immune 
responses in individual gnotobiotic groups. 
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Establishment of H. bilis and B. hyodysenteriae infections in GF mice. 
The establishment of H. bilis and B. hyodysenteriae infections in GF mice will be 
performed as previously described. Dual infected GF mice will be first orally infected with 
H. bilis, followed 21 days later by oral administration with 2 x 108 B. hyodysenteriae 
organisms. 
Assessment of immunopathoiogic parameters. 
Following euthanasia, samples will be taken for assessment of gross cecal lesions, 
histopathology, immunohistochemistry, bacteriology, analysis of antigen-specific serum 
antibodies, B cell ELISPOT, and cytokine analysis. These results will be compared between 
Type A and Type B ASF members, with Type A members predicted to elicit greater Th2 
immune responses, especially in dual infected GF mice. 
Identification of ASF species using a fluorescent in situ hybridization technique. 
Although previous data indicate that immune responses to select ASF members 
occur, confirmation of their mucosal location (e.g. intraluminal versus attaching) has not 
been performed. Furthermore, immune responses may be influenced by relative 
concentrations of select ASF. Fluorescent in situ hybridization (FISH) with probes targeting 
each ASF member will be used to quantitatively detect the presence and location of these 
bacteria. A limited number of probes are available targeting gut-associated bacteria. 
Prospective FISH probes will be validated experimentally for each bacterium in the ASF. If 
necessary, additional probes targeting 16S rRNA will be designed using Vector NTI software 
package (InfoMax, Bethesda, MD) with GenBank and RDP databases. Specificity of probes 
will be determined experimentally. Tissues will be formaldehyde-fixed at time of necropsy 
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and stored at -20°C until hybridized. One to three probes, with different fluorescent labels, 
will be hybridized to a sample in a single operation following standard FISH protocols. 
Hybridized samples will be visualized and images captured using a fluorescence microscope 
fitted with a digital camera and imaging software. These studies will be performed under the 
guidance of Dr. Cherie Ziemer's laboratory at the USD A. 
Anticipated Results 
It is our intent to use these gnotobiotic GF mice colonized with a subset of the 
ASF organisms to identify which collection of ASF bacteria is most important in driving host 
immune responses. It is our expectation that infection of GF mice with Type B ASF bacteria 
(e.g., less immunogenic species) will evoke less immunologic responses as compared to 
Type A ASF bacteria which tend to be more immunogenic. Based on our previous data, we 
surmise that immune responses to ASF bacteria following H. bilis infection will be 
predominantly Th2-like, while immune responses to ASF bacteria following B. 
hyodysenteriae infection will be characteristically Thl-like. Thus, GF mice infected with H. 
bilis should have no gross and histologic lesions, similar to non-infected GF controls. In 
contrast, GF mice infected with B. hyodysenteriae will have significant mucosal 
inflammation as a consequence of Thl-mediated responses to their ASF bacteria. Lastly, 
dual-infected GF mice should have intestinal inflammation of intermediate severity between 
these two extremes as Th2 responses elicited by the presence of H. bilis with the ASF flora 
modulate (down-regulate) the Thl-driven immunity to B. hyodysenteriae. 
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Potential Difficulties, Limitations, and Alternative Approaches 
Arguably, the optimal time point for evaluation of C3H GF mice has not been 
established. The choice of PI day 75 for necropsy is arbitrarily based on very limited pilot 
studies in GF BALB/c mice which failed to demonstrate consistent intestinal lesions until 60-
70 days following B. hyodysenteriae infection. It is quite possible that our expected results 
may vary since we will be evaluating the gnotobiotic mice later in disease progression and 
we will be evaluating subsets of the ASF bacteria rather than the total ASF flora. It is also 
possible that some of the ASF organisms may not induce detectable immune responses 
regardless of the time that evaluation occurs. 
There are also some potential pitfalls regarding FISH analysis of the flora. 
Preparation of gut wall samples will require some adaptation of other established procedures. 
Only 2 of the ASF strains have been typed as species which may require some 16S rDNA 
sequencing to determine where they fall prior to application or design of probes. This may 
need to be done for all ASF members in order to confirm 16S rDNA phylogeny for correctly 
determining target sequences (even for using available probes but especially for designing 
probes). If the Clostridium and Lactobacillus strains are too closely related it may be 
difficult or even impossible to develop probes specific enough to differentiate among them. 
FUTURE STUDIES ANTICIPATED OVER THE NEXT 3-5 YEARS 
Experiments during this time frame will be in line with the long term goals of our 
laboratory and will evolve, to some degree, on results generated from the germ-free mouse 
studies. We have previously shown that the introduction of H. bilis into gnotobiotic mice 
which are subsequently co-infected with B. hyodysenteriae alters host immune responses to 
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bacterial antigens modulating the severity of colitis. This response might be mediated 
through bacterial-epithelial cell interactions which in turn produce cytokines, chemokines, 
and other mediators which induce activation of the mucosal immune system. Several recent 
reports have demonstrated altered epithelial gene products involved in mucosal defense and 
inflammation associated with ubiquitous enteric bacteria. We hypothesize that Type A and 
Type B ASF bacteria will differ in their ability to modulate colitis in gnotobiotic mice, and 
that these differences will be associated with induction of different epithelial gene products 
which may be detected using microarray analysis and/or real time PGR. These procedures 
will be performed on intestinal specimens previously obtained from each group of 
gnotobiotic mice archived during completion of the germ-free studies. Gene expression in 
gnotobiotic mice will also be compared to that observed in conventional mice. This novel 
approach will allow the identification of known, and perhaps novel, gene products involved 
in mucosal defense against luminal microorganisms and their associated inflammatory 
response. 
Mechanisms by which immune responses to the enteric microflora are controlled 
so that chronic inflammation does not occur in the gut have recently been demonstrated. Of 
interest, IL-10 deficient but not wild-type (WT) mice develop colitis after infection with 
Helicobacter hepaticus. Using a modification of the CD4/SCIDIBD model, investigators 
induced colitis in H. hepaticus-infected recombination activation gene (RAG) knockout (KO) 
mice by the transfer of CD4+ T cells from infected, colitic, IL-10 KO mice. They 
subsequently analyzed the disease protective effects of the co-transfer of various CD4+ 
populations from WT mice. Results indicate that H. hepaticus infection induces a distinct 
population in WT mice of regulatory CD4+CD25+ T cells which prevent bacterial-induced 
107 
colitis. The contribution of responses induced by antigens derived from the normal flora 
were not examined. These data were determined in mice colonized with a conventional, 
complex flora and whose immune responses were evaluated shortly after H. hepaticus 
infection. 
We propose to further investigate the interaction between H. bilis and the normal 
flora in the development of a regulatory T (Treg) cell response by studying changes in the 
responses of the Treg cells recovered from the mucosa and MLN. It is unknown whether or 
not the Treg cell response persists over time. For these studies, gnotobiotic mice will be 
infected with H. bilis and the cecal mucosa and MLN will be collected at various times after 
colonization. The CD45RBlow population of CD4+ T cells will be collected and stimulated 
with antigens from H. bilis or antigens of the ASF organisms. The CD4+CD45RBlow Treg 
cells will be enriched using magnetic bead separation (for CD4) and cell sorting (for the 
CD45RBl0W population) using a flow cytometer. The recovered cells will be stimulated in 
vitro with specific antigens in the presence of IL-2 and culture supematants will be analyzed 
for the production of IL-10 and/or TGF-J3. These data will indicate whether Treg cells are 
responsive to H. bilis antigens as well as to antigens derived from the normal flora. In 
addition, evaluating this response at several time points will provide evidence as to when this 
response in maximal and whether the response is differentially induced by antigens from the 
various members of defined flora. 
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